<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK107219" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK107219/" /><meta name="ncbi_pagename" content="MUTYH Polyposis - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>MUTYH Polyposis - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="MUTYH Polyposis" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/10/10" /><meta name="citation_author" content="Maartje Nielsen" /><meta name="citation_author" content="Elena Infante" /><meta name="citation_author" content="Randall Brand" /><meta name="citation_pmid" content="23035301" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK107219/" /><meta name="citation_keywords" content="Multiple Colorectal Adenomas, Autosomal Recessive" /><meta name="citation_keywords" content="MUTYH-Associated Polyposis (MAP)" /><meta name="citation_keywords" content="Multiple Colorectal Adenomas, Autosomal Recessive" /><meta name="citation_keywords" content="MUTYH-Associated Polyposis (MAP)" /><meta name="citation_keywords" content="Adenine DNA glycosylase" /><meta name="citation_keywords" content="MUTYH" /><meta name="citation_keywords" content="MUTYH Polyposis" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="MUTYH Polyposis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Maartje Nielsen" /><meta name="DC.Contributor" content="Elena Infante" /><meta name="DC.Contributor" content="Randall Brand" /><meta name="DC.Date" content="2019/10/10" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK107219/" /><meta name="description" content="MUTYH polyposis (also referred to as MUTYH-associated polyposis, or MAP) is characterized by a greatly increased lifetime risk of colorectal cancer (CRC). Although typically associated with ten to a few hundred colonic adenomatous polyps, CRC develops in some individuals in the absence of polyposis. Serrated adenomas, hyperplastic/sessile serrated polyps, and mixed (hyperplastic and adenomatous) polyps can also occur. Duodenal adenomas are common, with an increased risk of duodenal cancer. The risk for malignancies of the ovary and bladder is also increased, and there is some evidence of an increased risk for breast and endometrial cancer. Additional reported features include thyroid nodules, benign adrenal lesions, jawbone cysts, and congenital hypertrophy of the retinal pigment epithelium." /><meta name="og:title" content="MUTYH Polyposis" /><meta name="og:type" content="book" /><meta name="og:description" content="MUTYH polyposis (also referred to as MUTYH-associated polyposis, or MAP) is characterized by a greatly increased lifetime risk of colorectal cancer (CRC). Although typically associated with ten to a few hundred colonic adenomatous polyps, CRC develops in some individuals in the absence of polyposis. Serrated adenomas, hyperplastic/sessile serrated polyps, and mixed (hyperplastic and adenomatous) polyps can also occur. Duodenal adenomas are common, with an increased risk of duodenal cancer. The risk for malignancies of the ovary and bladder is also increased, and there is some evidence of an increased risk for breast and endometrial cancer. Additional reported features include thyroid nodules, benign adrenal lesions, jawbone cysts, and congenital hypertrophy of the retinal pigment epithelium." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK107219/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/maps/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK107219/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CEE00E04048610000000006890249.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK107219_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK107219_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mpv17-mtdep/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/myh9/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK107219_"><span class="title" itemprop="name"><i>MUTYH</i> Polyposis</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Multiple Colorectal Adenomas, Autosomal Recessive; <i>MUTYH</i>-Associated Polyposis (MAP)</div><p class="contrib-group"><span itemprop="author">Maartje Nielsen</span>, MD, <span itemprop="author">Elena Infante</span>, MS, CGC, and <span itemprop="author">Randall Brand</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK107219_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK107219_ai__"><div class="contrib half_rhythm"><span itemprop="author">Maartje Nielsen</span>, MD<div class="affiliation small">Department of Clinical Genetics<br />Leiden University Medical Center<br />Leiden, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmul@neslein.m" class="oemail">ln.cmul@neslein.m</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Elena Infante</span>, MS, CGC<div class="affiliation small">Department of Pediatrics<br />Division of Medical Genetics<br />UPMC Children&#x02019;s Hospital of Pittsburgh<br />Pittsburgh, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmpu@meetnafni" class="oemail">ude.cmpu@meetnafni</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Randall Brand</span>, MD<div class="affiliation small">Department of Medicine<br />Division of Gastroenterology, Hepatology, and Nutrition<br />University of Pittsburgh<br />Pittsburgh, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ttip@erdnarb" class="oemail">ude.ttip@erdnarb</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 4, 2012</span>; Last Update: <span itemprop="dateModified">October 10, 2019</span>.</p><p><em>Estimated reading time: 29 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="maps.Summary" itemprop="description"><h2 id="_maps_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>MUTYH</i> polyposis (also referred to as <i>MUTYH</i>-associated polyposis, or MAP) is characterized by a greatly increased lifetime risk of colorectal cancer (CRC). Although typically associated with ten to a few hundred colonic adenomatous polyps, CRC develops in some individuals in the absence of polyposis. Serrated adenomas, hyperplastic/sessile serrated polyps, and mixed (hyperplastic and adenomatous) polyps can also occur. Duodenal adenomas are common, with an increased risk of duodenal cancer. The risk for malignancies of the ovary and bladder is also increased, and there is some evidence of an increased risk for breast and endometrial cancer. Additional reported features include thyroid nodules, benign adrenal lesions, jawbone cysts, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hypertrophy of the retinal pigment epithelium.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>MUTYH</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Suspicious polyps identified on colonoscopy should be removed until polypectomy alone cannot manage the large size and density of the polyps, at which point either subtotal colectomy or proctocolectomy is performed. Duodenal polyps showing dysplasia or villous changes should be excised during endoscopy. Abnormal findings on thyroid ultrasound examination should be evaluated by a thyroid specialist to determine what combination of monitoring, surgery, and/or fine needle aspiration is appropriate.</p><p><i>Surveillance:</i> Colonoscopy with polypectomy every one to two years beginning at age 25-30 years; upper endoscopy and side viewing duodenoscopy every three months to four years beginning at age 30-35 years with subsequent follow up based on initial findings. Consider annual physical examination, thyroid ultrasound, and skin examination by a dermatologist.</p><p>Individuals with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>: offer average moderate-risk colorectal screening based on family history.</p><p><i>Evaluation of relatives at risk:</i> It is appropriate to clarify the genetic status of apparently asymptomatic older and younger sibs of an individual with MAP by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>MUTYH</i> pathogenic variants identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to reduce morbidity and mortality in those who would benefit from appropriate surveillance beginning at age 10-15 years and early identification and treatment of polyps.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>MAP is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> with a small increased risk for CRC, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified.</p></div></div><div id="maps.Diagnosis"><h2 id="_maps_Diagnosis_">Diagnosis</h2><div id="maps.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>MUTYH</i> polyposis (MAP) <b>should be suspected</b> in an individual with the following clinical findings and family history [<a class="bk_pop" href="#maps.REF50">NCCN 2019</a>].</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>A personal cumulative lifetime history of ten or more colorectal adenomas in an individual age &#x02264;60 years</div></li><li class="half_rhythm"><div>A personal cumulative lifetime history of 20 or more colorectal adenomas in an individual of any age</div></li><li class="half_rhythm"><div>A personal cumulative lifetime history of any combination of 20 or more colorectal adenomas, hyperplastic polyps, and/or sessile serrated polyps (excluding rectal and sigmoid hyperplastic polyps)</div></li><li class="half_rhythm"><div>Sessile serrated polyposis syndrome:</div><ul><li class="half_rhythm"><div>At least five serrated polyps proximal to the sigmoid colon, of which two or more are &#x0003e;10 mm; OR</div></li><li class="half_rhythm"><div>&#x0003e;20 serrated polyps of any size distributed throughout the colon (excluding hyperplastic polyps found in the rectum and sigmoid colon)</div></li></ul></li><li class="half_rhythm"><div>Duodenal polyp(s) and/or duodenal cancer</div></li><li class="half_rhythm"><div>Colorectal cancer with or without a history of polyps and identification of a somatic <i>KRAS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (c.34G&#x0003e;T in codon 12) or identification of specific mutational signature on tumor tissue testing due to a high percentage of somatic G&#x0003e;T transversions (e.g., COSMIC Signature 18; SigProfiler SBS18/SBS36; SignatureAnalyzer SBS18/SBS36) [<a class="bk_pop" href="#maps.REF.viel.2017.39">Viel et al 2017</a>].</div></li></ul><p><b>Family history</b> of colorectal cancer (&#x000b1; polyps) consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance.</p></div><div id="maps.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of MAP <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MUTYH</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK107219/table/maps.T.germline_molecular_genetic_testin/?report=objectonly" target="object" rid-figpopup="figmapsTgermlinemoleculargenetictestin" rid-ob="figobmapsTgermlinemoleculargenetictestin">Table 1</a> and <a class="figpopup" href="/books/NBK107219/table/maps.T.detection_frequency_of_biallelic/?report=objectonly" target="object" rid-figpopup="figmapsTdetectionfrequencyofbiallelic" rid-ob="figobmapsTdetectionfrequencyofbiallelic">Table 2</a>).</p><p><b>Germline <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a></b> approaches can include <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing and/or <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>). Since the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of MAP (as described in <a href="#maps.Suggestive_Findings">Suggestive Findings</a>) overlaps with a number of other hereditary polyposis and colorectal cancer syndromes (see <a href="#maps.Differential_Diagnosis">Differential Diagnosis</a>), many individuals with MAP will likely be diagnosed using a multigene panel.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>MUTYH</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications (<a class="figpopup" href="/books/NBK107219/table/maps.T.germline_molecular_genetic_testin/?report=objectonly" target="object" rid-figpopup="figmapsTgermlinemoleculargenetictestin" rid-ob="figobmapsTgermlinemoleculargenetictestin">Table 1</a>).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>MUTYH</i> and other genes of interest (see <a href="#maps.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK107219/table/maps.T.germline_molecular_genetic_testin/?report=objectonly" target="object" rid-figpopup="figmapsTgermlinemoleculargenetictestin" rid-ob="figobmapsTgermlinemoleculargenetictestin">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="maps.T.germline_molecular_genetic_testin" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Germline Molecular Genetic Testing Used in <i>MUTYH</i> Polyposis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK107219/table/maps.T.germline_molecular_genetic_testin/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__maps.T.germline_molecular_genetic_testin_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_maps.T.germline_molecular_genetic_testin_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_maps.T.germline_molecular_genetic_testin_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_maps.T.germline_molecular_genetic_testin_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_maps.T.germline_molecular_genetic_testin_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>MUTYH</i></td><td headers="hd_h_maps.T.germline_molecular_genetic_testin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_maps.T.germline_molecular_genetic_testin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_maps.T.germline_molecular_genetic_testin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_maps.T.germline_molecular_genetic_testin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 6</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="maps.TF.1.1"><p class="no_margin">See <a href="/books/NBK107219/#maps.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="maps.TF.1.2"><p class="no_margin">See <a href="#maps.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="maps.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="maps.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#maps.REF.out.2010.1205">Out et al [2010]</a></p></div></dd><dt>5. </dt><dd><div id="maps.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="maps.TF.1.6"><p class="no_margin">A large (&#x0003e;4.2-kb) <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> encompassing exons 4-16 has been reported in three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from Spain, France, and Brazil, indicating a possible southern European <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> [<a class="bk_pop" href="#maps.REF.rouleau.2011.301">Rouleau et al 2011</a>, <a class="bk_pop" href="#maps.REF.torrezan.2011.128">Torrezan et al 2011</a>, <a class="bk_pop" href="#maps.REF.castillejo.2014.2241">Castillejo et al 2014</a>]. A deletion of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 15 has also been reported [<a class="bk_pop" href="#maps.REF.ricci.2017.309">Ricci et al 2017</a>].</p></div></dd></dl></div></div></div><div id="maps.T.detection_frequency_of_biallelic" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Detection Frequency of Biallelic Germline <i>MUTYH</i> Pathogenic Variants by Number of Polyps in Individuals with <i>APC</i> Mutation-Negative Polyposis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK107219/table/maps.T.detection_frequency_of_biallelic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__maps.T.detection_frequency_of_biallelic_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Number of Polyps</th><th id="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Detection Frequency of Biallelic Germline <i>MUYTH</i> Pathogenic Variants</th></tr></thead><tbody><tr><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1-19</td><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2% (25/1,430)</td></tr><tr><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">10-19</td><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">2% (58/2,634)</td></tr><tr><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">20-49</td><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">11% (60/540)</td></tr><tr><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">20-99</td><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">7% (306/4,425)</td></tr><tr><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">50-99</td><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">21% (22/107)</td></tr><tr><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">100-999</td><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">16% (133/809)</td></tr><tr><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003e;1,000</td><td headers="hd_h_maps.T.detection_frequency_of_biallelic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">8% (2/24)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Based on <a class="bk_pop" href="#maps.REF.grover.2012.485">Grover et al [2012]</a>, <a class="bk_pop" href="#maps.REF.stanich.2019.2008">Stanich et al [2019]</a>, <a class="bk_pop" href="#maps.REF.terlouw.2019">Terlouw et al [2019]</a></p></div></dd></dl></div></div></div><p><b>Tumor tissue testing prior to <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> is generally not required; however, it may be required in certain circumstances (e.g., by third-party payer policy). In other instances, review of past tumor testing on a proband may help determine the preferred germline molecular genetic testing approach (i.e., single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing vs use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>).</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Identification of a somatic <i>KRAS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> The <i>KRAS</i> pathogenic variant (c.34G&#x0003e;T in codon 12), present in less than 5%-10% of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> colorectal cancers (CRCs), is found in 40%-100% of adenomas and 60%-90% of CRCs in persons with MAP [<a class="bk_pop" href="#maps.REF.nielsen.2011.1">Nielsen et al 2011</a>, <a class="bk_pop" href="#maps.REF.viel.2017.39">Viel et al 2017</a>]. Furthermore, 10%-25% of persons with CRCs with this somatic <i>KRAS</i> variant have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>MUTYH</i> pathogenic variants.</div><div class="half_rhythm"><i>KRAS</i> somatic <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is often routine in advanced CRCs to identify individuals who are eligible for <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> molecular genetic testing, including probands with atypical clinical findings (CRC and no or very few adenomas) [<a class="bk_pop" href="#maps.REF.van_puijenbroek.2008.139">van Puijenbroek et al 2008</a>, <a class="bk_pop" href="#maps.REF.guarinos.2014.1158">Guarinos et al 2014</a>, <a class="bk_pop" href="#maps.REF.aim_.2015.390">Aim&#x000e9; et al 2015</a>, <a class="bk_pop" href="#maps.REF.viel.2017.39">Viel et al 2017</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Microsatellite instability (MSI)-low</b> (For information on MSI testing including advantages and disadvantages, click <a href="/books/NBK107219/bin/hnpcc-msi.pdf">here</a>). Although the majority of CRCs in persons with MAP are <a class="def" href="/books/n/gene/glossary/def-item/microsatellite/">microsatellite</a> stable, the MSI-high <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is found in a minority (0%-18%, mean: 4%) (see review in <a class="bk_pop" href="#maps.REF.nielsen.2011.1">Nielsen et al [2011]</a>, <a class="bk_pop" href="#maps.REF.castillejo.2014.2241">Castillejo et al [2014]</a>).</div></li></ul></div></div><div id="maps.Clinical_Characteristics"><h2 id="_maps_Clinical_Characteristics_">Clinical Characteristics</h2><div id="maps.Clinical_Description"><h3>Clinical Description</h3><p><i>MUTYH</i> polyposis (<i>MUTYH</i>-associated polyposis; MAP) is characterized by a greatly increased lifetime risk for colorectal cancer (CRC) (43%-63% at age 60 years and a lifetime risk of 80%-90% in the absence of timely surveillance). The risk for malignancies of the duodenum, ovary, and bladder is also increased, and there is some evidence of an increased risk for breast and endometrial cancer (<a class="figpopup" href="/books/NBK107219/table/maps.T.cancer_risks_in_individuals_with/?report=objectonly" target="object" rid-figpopup="figmapsTcancerrisksinindividualswith" rid-ob="figobmapsTcancerrisksinindividualswith">Table 3</a>).</p><div id="maps.T.cancer_risks_in_individuals_with" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Cancer Risks in Individuals with <i>MUTYH</i> Polyposis Compared to the General Population</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK107219/table/maps.T.cancer_risks_in_individuals_with/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__maps.T.cancer_risks_in_individuals_with_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cancer Type</th><th id="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">General<br />Population Risk&#x000a0;<sup>1</sup></th><th id="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Risk Associated with MAP&#x000a0;<sup>2</sup></th><th id="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Median Age<br />of Onset</th></tr></thead><tbody><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Colorectal</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.5%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43%-63% by age 60 yrs; 80%-90% lifetime risk w/out surveillance</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">48 yrs</td></tr><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Duodenal</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;0.3%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">61 yrs</td></tr><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ovarian</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.3%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%-14%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">51 yrs</td></tr><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Bladder</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%-4%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%-8% in females; 6%-25% in males</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">61 yrs</td></tr><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Breast</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12%-25%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">53 yrs</td></tr><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endometrial</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2.9%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~3%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">51 yrs</td></tr><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastric</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;0.7%-1%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">38 yrs</td></tr><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pancreatic</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.6%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skin</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~20%&#x000a0;<sup>4</sup></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">See footnote 3</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Thyroid</b></td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.6%-1.8%</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">See footnote 3</td><td headers="hd_h_maps.T.cancer_risks_in_individuals_with_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="maps.TF.3.1"><p class="no_margin">US National Cancer Institute's <a href="https://seer.cancer.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Surveillance Epidemiology and End Results (SEER) Database</a> 2012-2014</p></div></dd><dt>2. </dt><dd><div id="maps.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#maps.REF.nielsen.2006.1212">Nielsen et al [2006]</a>, <a class="bk_pop" href="#maps.REF.lubbe.2009.3975">Lubbe et al [2009]</a>, <a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al [2009]</a>, <a class="bk_pop" href="#maps.REF.win.2014">Win et al [2014]</a>, <a class="bk_pop" href="#maps.REF.walton.2016.986">Walton et al [2016]</a></p></div></dd><dt>3. </dt><dd><div id="maps.TF.3.3"><p class="no_margin">Unclear if the risk for this type of cancer is increased in individuals with MAP</p></div></dd><dt>4. </dt><dd><div id="maps.TF.3.4"><p class="no_margin">Including basal cell carcinoma</p></div></dd></dl></div></div></div><p><b>Colon polyps and cancer.</b> Most individuals with MAP have between ten and a few hundred colonic polyps with a mean age of presentation of approximately 50 years. Persons with MAP can have colonic adenomas as well as serrated adenomas, hyperplastic/sessile serrated polyps, and mixed (hyperplastic and adenomatous) polyps [<a class="bk_pop" href="#maps.REF.sieber.2003.791">Sieber et al 2003</a>, <a class="bk_pop" href="#maps.REF.chow.2006.30">Chow et al 2006</a>, <a class="bk_pop" href="#maps.REF.boparai.2008.2014">Boparai et al 2008</a>, <a class="bk_pop" href="#maps.REF.oshea.2008.184">O'Shea et al 2008</a>]. Of note, eight of 17 persons with MAP had one or more hyperplastic colonic polyps and/or sessile serrated adenomas; findings in three of these eight individuals met criteria for the serrated polyposis syndrome (see <a href="#maps.Differential_Diagnosis">Differential Diagnosis</a>) [<a class="bk_pop" href="#maps.REF.boparai.2008.2014">Boparai et al 2008</a>]. A rectal clustering (studding) of a large number (i.e., &#x0003e;20) of hyperplastic polyps was found in ten of 16 persons with MAP [<a class="bk_pop" href="#maps.REF.church.2016.565">Church &#x00026; Kravochuck 2016</a>].</p><p>Molecular genetic testing of individuals with CRC has revealed that up to one third of persons with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>MUTYH</i> pathogenic variants develop CRC in the absence of colonic polyposis [<a class="bk_pop" href="#maps.REF.croitoru.2004.1631">Croitoru et al 2004</a>, <a class="bk_pop" href="#maps.REF.farrington.2005.112">Farrington et al 2005</a>, <a class="bk_pop" href="#maps.REF.balaguer.2007.379">Balaguer et al 2007</a>, <a class="bk_pop" href="#maps.REF.cleary.2009.1251">Cleary et al 2009</a>, <a class="bk_pop" href="#maps.REF.pearlman.2017.464">Pearlman et al 2017</a>]. In a minority (0%-3.7%) of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, biallelic germline <i>MUTYH</i> pathogenic variants have been found in the index case of a family with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> suggestive of <a href="/books/n/gene/hnpcc/">Lynch Syndrome</a> [<a class="bk_pop" href="#maps.REF.nielsen.2011.1">Nielsen et al 2011</a>, <a class="bk_pop" href="#maps.REF.castillejo.2014.2241">Castillejo et al 2014</a>].</p><p>In the absence of timely surveillance, the lifetime risk for CRC in individuals with MAP was between 80% and 90% [<a class="bk_pop" href="#maps.REF.lubbe.2009.3975">Lubbe et al 2009</a>, <a class="bk_pop" href="#maps.REF.win.2014">Win et al 2014</a>]. Colon cancers were found to be right-sided in 29%-69% of individuals with MAP [<a class="bk_pop" href="#maps.REF.lipton.2003.7595">Lipton et al 2003</a>, <a class="bk_pop" href="#maps.REF.oshea.2008.184">O'Shea et al 2008</a>, <a class="bk_pop" href="#maps.REF.nielsen.2009a.184">Nielsen et al 2009a</a>]. Metachronous or synchronous colon cancers occurred in 23%-27% of individuals with MAP [<a class="bk_pop" href="#maps.REF.lipton.2003.7595">Lipton et al 2003</a>, <a class="bk_pop" href="#maps.REF.nielsen.2009a.184">Nielsen et al 2009a</a>].</p><p>In one report, survival of individuals with <i>MUTYH</i> CRC on average was better than survival in individuals with colorectal adenocarcinoma and unknown family history who did not have <a class="def" href="/books/n/gene/glossary/def-item/microsatellite/">microsatellite</a> instability testing [<a class="bk_pop" href="#maps.REF.nielsen.2010.1724">Nielsen et al 2010</a>]. Five-year survival for persons with MAP CRC was 78% (which, after adjustment for differences in age, stage, sex, subsite, country, and year of diagnosis, remained better than for controls).</p><p><b>Duodenal polyps and cancer.</b> Duodenal polyps occur in 17%-34% of individuals with MAP. The lifetime risk for duodenal cancer is approximately 4% [<a class="bk_pop" href="#maps.REF.nielsen.2006.1212">Nielsen et al 2006</a>, <a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>, <a class="bk_pop" href="#maps.REF.walton.2016.986">Walton et al 2016</a>].</p><p><b>Ovarian cancer.</b> The incidence of ovarian cancer was significantly increased in women with MAP, with a lifetime risk of 6%-14% and median age at diagnosis of 51 years [<a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>, <a class="bk_pop" href="#maps.REF.win.2016.1557">Win et al 2016</a>]. Biallelic <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>MUTYH</i> pathogenic variants were uncommon in a large cohort of women with ovarian cancer (1/7,646) [<a class="bk_pop" href="#maps.REF.laduca.2019">LaDuca et al 2019</a>].</p><p><b>Bladder cancer.</b> The incidence of bladder cancer was significantly increased, with a lifetime risk of 6%-8% for females and 6%-25% for males with MAP and a median age at diagnosis of 61 years (range 45-67) [<a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>, <a class="bk_pop" href="#maps.REF.win.2016.1557">Win et al 2016</a>].</p><p><b>Other cancers</b></p><ul><li class="half_rhythm"><div><b>Breast cancer.</b> It is unclear if the risk for breast cancer is increased in women with MAP. The risk was found to be higher in one study, with median age at diagnosis 53 years (range 45-76) [<a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>]. However, a second study did not find an increased breast cancer risk [<a class="bk_pop" href="#maps.REF.win.2016.1557">Win et al 2016</a>]. Although <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>MUTYH</i> pathogenic variants have not been reported in individuals from large breast cancer cohorts, one male with biallelic germline <i>MUTYH</i> pathogenic variants was reported in a cohort of 560 males with breast cancer [<a class="bk_pop" href="#maps.REF.rizzolo.2018.583">Rizzolo et al 2018</a>].</div></li><li class="half_rhythm"><div><b>Endometrial cancer</b> was diagnosed in two of 118 women with MAP, with a median age at diagnosis of 51 years and a lifetime risk of approximately 3% [<a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>]. <a class="bk_pop" href="#maps.REF.sutcliffe.2019.203">Sutcliffe et al [2019]</a> reported endometrial cancer in four of 45 women with MAP.</div></li><li class="half_rhythm"><div><b>Gastric fundic gland polyps and gastric cancer.</b> Among 150 individuals with MAP undergoing endoscopic surveillance, 17 (11%) had gastric fundic gland polyps. Although a higher risk for gastric cancer than in the general population was observed, the trend was not significant [<a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>].</div></li><li class="half_rhythm"><div><b>Pancreatic cancer.</b> Two (2%) of 83 individuals with MAP were diagnosed with pancreatic cancer [<a class="bk_pop" href="#maps.REF.sutcliffe.2019.203">Sutcliffe et al 2019</a>]. Two additional studies including 276 individuals with MAP did not report any instances of pancreatic cancer [<a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>, <a class="bk_pop" href="#maps.REF.win.2016.1557">Win et al 2016</a>].</div></li><li class="half_rhythm"><div><b>Skin cancer.</b> Thirteen of 276 individuals with MAP had a diagnosis of skin cancer including melanomas, squamous epithelial carcinomas, and basal cell cancers [<a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>]. In this same cohort, five individuals also had sebaceous gland adenomas or sebaceous gland epitheliomas. Another study reported two melanomas and six other skin cancers in 81 individuals with MAP [<a class="bk_pop" href="#maps.REF.sutcliffe.2019.203">Sutcliffe et al 2019</a>].</div></li><li class="half_rhythm"><div><b>Thyroid cancer.</b> Three of 24 individuals with MAP evaluated by thyroid ultrasound had papillary thyroid cancer [<a class="bk_pop" href="#maps.REF.laguardia.2011">LaGuardia et al 2011</a>]; a high incidence of thyroid cancer was not reported in other studies and may have reflected selection bias. <a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al [2009]</a> reported two instances of thyroid cancer in 276 individuals with MAP.</div></li></ul><p><b>Other extraintestinal findings in persons with MAP</b></p><ul><li class="half_rhythm"><div>Thyroid nodules were identified in 16 of 24 individuals with MAP examined by ultrasound [<a class="bk_pop" href="#maps.REF.laguardia.2011">LaGuardia et al 2011</a>]. A second study reported thyroid nodules in two of 82 individuals with MAP [<a class="bk_pop" href="#maps.REF.sutcliffe.2019.203">Sutcliffe et al 2019</a>].</div></li><li class="half_rhythm"><div><b>Adrenal lesions</b> (all benign and not hyperfunctioning) were identified in five (18%) of 21 of individuals with MAP in a prospective study [<a class="bk_pop" href="#maps.REF.kallenberg.2017.1057">Kallenberg et al 2017</a>].</div></li><li class="half_rhythm"><div><b>Dental abnormalities.</b> Jawbone cysts were reported in 11 of 276 persons with MAP [<a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>].</div></li><li class="half_rhythm"><div><b>Congenital hypertrophy of retinal pigment epithelium (CHRPE).</b> The estimate of CHRPE in individuals with MAP is about 5.5%; however, this figure may also include misdiagnoses since pigment anomalies of the retina are quite frequent in the general population [<a class="bk_pop" href="#maps.REF.vogt.2009">Vogt et al 2009</a>].</div></li></ul><div id="maps.Heterozygotes"><h4>Heterozygotes</h4><p>The risk for CRC in individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was only marginally increased in large population-based and family-based studies [<a class="bk_pop" href="#maps.REF.jenkins.2006.312">Jenkins et al 2006</a>, <a class="bk_pop" href="#maps.REF.jones.2009.489">Jones et al 2009</a>, <a class="bk_pop" href="#maps.REF.win.2014">Win et al 2014</a>]. In a prospective study of 62 <i>MUTYH</i> heterozygotes, the frequency of colonic and upper GI polyps was not increased [<a class="bk_pop" href="#maps.REF.el_hachem.2019.470">El Hachem et al 2019</a>].</p><p>The risk of developing extraintestinal cancer in <i>MUTYH</i> heterozygotes is unclear. A slightly increased cumulative risk for <i>MUTYH</i> heterozygotes for gastric, hepatobiliary, endometrial, and breast cancer was reported by <a class="bk_pop" href="#maps.REF.win.2016.1557">Win et al [2016]</a>. Other case-control studies did not find an association between <i>MUTYH</i> heterozygosity and risk for breast cancer or hepatocellular carcinoma [<a class="bk_pop" href="#maps.REF.baudhuin.2006.159">Baudhuin et al 2006</a>, <a class="bk_pop" href="#maps.REF.beiner.2009.575">Beiner et al 2009</a>, <a class="bk_pop" href="#maps.REF.out.2012.219">Out et al 2012</a>, <a class="bk_pop" href="#maps.REF.fulk.2019.197">Fulk et al 2019</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in two of 45 individuals with neuroendocrine tumors (NET) of the pancreas and eight of 160 individuals with adrenocortical carcinomas (ACC) [<a class="bk_pop" href="#maps.REF.pilati.2017.10">Pilati et al 2017</a>, <a class="bk_pop" href="#maps.REF.scarpa.2017.65">Scarpa et al 2017</a>]. Two of 15 probands with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> NET of the small intestine and four of 215 individuals with nonfamilial NET of the small intestine were heterozygous for <i>MUTYH</i> pathogenic variant <a class="figpopup" href="/books/NBK107219/table/maps.T.notable_mutyh_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figmapsTnotablemutyhpathogenicvariants" rid-ob="figobmapsTnotablemutyhpathogenicvariants">p.Gly396Asp</a> [<a class="bk_pop" href="#maps.REF.dumanski.2017.427">Dumanski et al 2017</a>]. It is unclear if a heterozygous <i>MUTYH</i> pathogenic variant is a risk factor for NET or ACC, as the risk of NET or ACC in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>MUTYH</i> pathogenic variants appears to be quite low.</p></div></div><div id="maps.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Functional studies have shown differences in glycosylase activity between the <a class="figpopup" href="/books/NBK107219/table/maps.T.notable_mutyh_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figmapsTnotablemutyhpathogenicvariants" rid-ob="figobmapsTnotablemutyhpathogenicvariants">c.536A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the <a class="figpopup" href="/books/NBK107219/table/maps.T.notable_mutyh_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figmapsTnotablemutyhpathogenicvariants" rid-ob="figobmapsTnotablemutyhpathogenicvariants">c.1187G&#x0003e;A</a> pathogenic variant [<a class="bk_pop" href="#maps.REF.banda.2017.202">Banda et al 2017</a>]. Differences were also seen in clinical manifestations: homozygosity for the <a class="figpopup" href="/books/NBK107219/table/maps.T.notable_mutyh_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figmapsTnotablemutyhpathogenicvariants" rid-ob="figobmapsTnotablemutyhpathogenicvariants">c.1187G&#x0003e;A</a> pathogenic variant was associated with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and an approximately eight-year-earlier age of onset compared to homozygosity for the <a class="figpopup" href="/books/NBK107219/table/maps.T.notable_mutyh_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figmapsTnotablemutyhpathogenicvariants" rid-ob="figobmapsTnotablemutyhpathogenicvariants">c.536A&#x0003e;G</a> pathogenic variant [<a class="bk_pop" href="#maps.REF.lubbe.2009.3975">Lubbe et al 2009</a>, <a class="bk_pop" href="#maps.REF.nielsen.2009b.471">Nielsen et al 2009b</a>, <a class="bk_pop" href="#maps.REF.terdiman.2009.1883">Terdiman 2009</a>, <a class="bk_pop" href="#maps.REF.morak.2010.353">Morak et al 2010</a>].</p><p>For other common variants, such as p.Glu324His, which has up to a 50% minor <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> in some populations [<a class="bk_pop" href="#maps.REF.banda.2017.202">Banda et al 2017</a>], association with cancer risk has been reported; however, the reported risks are not consistent with mendelian inheritance and are not used to direct patient care.</p></div><div id="maps.Nomenclature"><h3>Nomenclature</h3><p>An outdated term for <i>MUTYH</i> polyposis is "<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> adenomatous polyposis."</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> formerly designated <i>MYH</i> is now <i>MUTYH</i>.</p></div><div id="maps.Prevalence"><h3>Prevalence</h3><p>It is estimated that 1%-2% of the general northern European, Australian, and US populations are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#maps.REF.altassan.2002.227">Al-Tassan et al 2002</a>, <a class="bk_pop" href="#maps.REF.cleary.2009.1251">Cleary et al 2009</a>, <a class="bk_pop" href="#maps.REF.win.2017.404">Win et al 2017</a>]. The Genome Aggregation Database (gnomAD) reports a somewhat lower frequency of <i>MUTYH</i> pathogenic variants (~0.8%). Using these figures, the prevalence of 1:20,000 to 1:60,000 for persons with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> germline <i>MUTYH</i> pathogenic variants can be derived.</p><p>MAP is estimated to account for 0.7% of all CRC and between 0.5% and 6% of cohorts of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> or early-onset CRC in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a low number of adenomas (&#x0003c;15-20) [<a class="bk_pop" href="#maps.REF.sieber.2003.791">Sieber et al 2003</a>, <a class="bk_pop" href="#maps.REF.cleary.2009.1251">Cleary et al 2009</a>, <a class="bk_pop" href="#maps.REF.lubbe.2009.3975">Lubbe et al 2009</a>, <a class="bk_pop" href="#maps.REF.landon.2015.368">Landon et al 2015</a>, <a class="bk_pop" href="#maps.REF.pearlman.2017.464">Pearlman et al 2017</a>]. See also <a class="figpopup" href="/books/NBK107219/table/maps.T.percentage_of_persons_with_map_by/?report=objectonly" target="object" rid-figpopup="figmapsTpercentageofpersonswithmapby" rid-ob="figobmapsTpercentageofpersonswithmapby">Table 4</a>.</p><div id="maps.T.percentage_of_persons_with_map_by" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Percentage of Persons with MAP by Age at Diagnosis of CRC</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK107219/table/maps.T.percentage_of_persons_with_map_by/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__maps.T.percentage_of_persons_with_map_by_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:top;">Persons with Biallelic <i>MUTYH</i> Pathogenic Variants</th><th id="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_2" style="text-align:left;vertical-align:middle;">Age at Diagnosis of CRC</th></tr><tr><th headers="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_1" id="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_2_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">% (n)</th><th headers="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_1" id="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Range</th></tr></thead><tbody><tr><td headers="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_1 hd_h_maps.T.percentage_of_persons_with_map_by_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1.3% (52/3,976)</td><td headers="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_1 hd_h_maps.T.percentage_of_persons_with_map_by_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0.5%-6.2%</td><td headers="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;50 years</td></tr><tr><td headers="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_1 hd_h_maps.T.percentage_of_persons_with_map_by_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0.3% (28/11,150)</td><td headers="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_1 hd_h_maps.T.percentage_of_persons_with_map_by_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0.0%-0.6%</td><td headers="hd_h_maps.T.percentage_of_persons_with_map_by_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003e;50 years</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Review of literature, <a class="bk_pop" href="#maps.REF.nielsen.2011.1">Nielsen et al [2011]</a>, <a class="bk_pop" href="#maps.REF.landon.2015.368">Landon et al [2015]</a>, <a class="bk_pop" href="#maps.REF.pearlman.2017.464">Pearlman et al [2017]</a></p></div></dd><dt></dt><dd><div><p class="no_margin">CRC = colorectal cancer</p></div></dd></dl></div></div></div></div></div><div id="maps.Genetically_Related_Allelic_Disorde"><h2 id="_maps_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>MUTYH</i>.</p></div><div id="maps.Differential_Diagnosis"><h2 id="_maps_Differential_Diagnosis_">Differential Diagnosis</h2><p><i>MUTYH</i> polyposis (MAP) can be distinguished from other inherited polyposis and colon cancer conditions by clinical findings, pathologic findings, <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Conditions to consider in the differential diagnosis include the disorders summarized in <a class="figpopup" href="/books/NBK107219/table/maps.T.disorders_to_consider_in_the_diff/?report=objectonly" target="object" rid-figpopup="figmapsTdisorderstoconsiderinthediff" rid-ob="figobmapsTdisorderstoconsiderinthediff">Table 5</a>.</p><div id="maps.T.disorders_to_consider_in_the_diff" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>MUTYH</i> Polyposis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK107219/table/maps.T.disorders_to_consider_in_the_diff/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__maps.T.disorders_to_consider_in_the_diff_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cancer Susceptibility Syndrome</th><th id="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s) /<br />Genetic<br />Mechanism</th><th id="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Polyps /<br />Colon Cancer</th><th id="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Associated<br />Malignancies</th><th id="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other Features /<br />Comments</th></tr></thead><tbody><tr><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fap/"><i>APC</i>-associated polyposis conditions</a></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>APC</i></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Attenuated FAP:
<ul><li class="half_rhythm"><div>0-100 colonic polyps</div></li><li class="half_rhythm"><div>CRC risk: 70%</div></li></ul>
FAP:
<ul><li class="half_rhythm"><div>100 colonic polyps</div></li><li class="half_rhythm"><div>Upper GI polyps</div></li><li class="half_rhythm"><div>CRC risk: 100%</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Small bowel</div></li><li class="half_rhythm"><div>Pancreatic</div></li><li class="half_rhythm"><div>Thyroid</div></li><li class="half_rhythm"><div>Liver</div></li><li class="half_rhythm"><div>Brain</div></li><li class="half_rhythm"><div>Bile duct</div></li><li class="half_rhythm"><div>Gastric</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>CHRPE</div></li><li class="half_rhythm"><div>Osteomas</div></li><li class="half_rhythm"><div>Supernumerary or missing teeth</div></li><li class="half_rhythm"><div>Cutaneous lesions</div></li><li class="half_rhythm"><div>Desmoid tumors</div></li></ul>
</td></tr><tr><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NTHL1-</i>associated polyposis<br />(OMIM <a href="http://omim.org/entry/616415" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616415</a>)</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NTHL1</i></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>8-50 adenomatous colonic polyps</div></li><li class="half_rhythm"><div>Duodenal adenomas</div></li><li class="half_rhythm"><div>CRC in 16/29 individuals</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Extracolonic cancer in 12/29 individuals:
<ul><li class="half_rhythm"><div>Uterine</div></li><li class="half_rhythm"><div>Duodenal</div></li><li class="half_rhythm"><div>Breast</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Premalignant endometrial lesions</div></li><li class="half_rhythm"><div>2nd most common AR form of colon cancer &#x00026; polyps after MAP&#x000a0;<sup>1</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hnpcc/">Lynch syndrome</a><br />(hereditary non-polyposis colon cancer)</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MLH1</i><br /><i>MSH2</i><br /><i>MSH6</i><br /><i>PMS2</i><br /><i>EPCAM</i></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>4% develop &#x02265;10 polyps</div></li><li class="half_rhythm"><div>Colon tumors often MSI+</div></li><li class="half_rhythm"><div>CRC risk: 52%-82%</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Uterine</div></li><li class="half_rhythm"><div>Ovarian</div></li><li class="half_rhythm"><div>Small bowel</div></li><li class="half_rhythm"><div>Gastric</div></li><li class="half_rhythm"><div>Urinary tract</div></li><li class="half_rhythm"><div>Skin</div></li><li class="half_rhythm"><div>Brain</div></li><li class="half_rhythm"><div>Hepatobiliary tract</div></li><li class="half_rhythm"><div>Pancreas</div></li><li class="half_rhythm"><div>Prostate</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pjs/">Peutz-Jeghers syndrome</a></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>STK11</i></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>GI hamartomatous polyps</div></li><li class="half_rhythm"><div>Polyps most often in small bowel</div></li><li class="half_rhythm"><div>Adenomatous colonic polyps can occur.</div></li><li class="half_rhythm"><div>CRC risk: 39%</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Gastric</div></li><li class="half_rhythm"><div>Breast</div></li><li class="half_rhythm"><div>Ovarian</div></li><li class="half_rhythm"><div>Small bowel</div></li><li class="half_rhythm"><div>Pancreas</div></li><li class="half_rhythm"><div>Cervix</div></li><li class="half_rhythm"><div>Uterine</div></li><li class="half_rhythm"><div>Lung</div></li><li class="half_rhythm"><div>Testicular</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ovarian sex cord tumors w/annular tubules</div></li><li class="half_rhythm"><div>Dk-brown to dk-blue melanocytic macules (fade w/age)</div></li></ul>
</td></tr><tr><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/jps/">Juvenile polyposis syndrome</a></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BMPR1A</i><br /><i>SMAD4</i></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hamartomatous (juvenile) polyps in small bowel, stomach, colon, &#x00026; rectum</div></li><li class="half_rhythm"><div>CRC risk: 38.7%</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Gastric</div></li><li class="half_rhythm"><div>Upper GI tract</div></li><li class="half_rhythm"><div>Pancreas</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hereditary hemorrhagic telangiectasia (<i>SMAD4-</i>related)</td></tr><tr><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/phts/"><i>PTEN</i> hamartoma tumor syndrome</a></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PTEN</i></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Multiple hamartomatous &#x00026; mixed polyps in GI tract</div></li><li class="half_rhythm"><div>CRC risk: 9%</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Breast</div></li><li class="half_rhythm"><div>Thyroid</div></li><li class="half_rhythm"><div>Uterine</div></li><li class="half_rhythm"><div>Renal</div></li><li class="half_rhythm"><div>Brain</div></li><li class="half_rhythm"><div>Melanoma</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Thyroid disease/nodules</div></li><li class="half_rhythm"><div>Uterine fibroids</div></li><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Lipomas</div></li><li class="half_rhythm"><div>Mucocutaneous lesions</div></li><li class="half_rhythm"><div>Pigmented macules of glans penis</div></li><li class="half_rhythm"><div>Hamartomatous overgrowth of tissues</div></li><li class="half_rhythm"><div>Connective tissue nevi</div></li><li class="half_rhythm"><div>Epidermal nevi</div></li><li class="half_rhythm"><div>Hyperostoses</div></li></ul>
</td></tr><tr><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hereditary mixed polyposis syndrome (OMIM <a href="http://omim.org/entry/610069" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610069</a>, <a href="http://omim.org/entry/601228" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601228</a>)</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BMPR1A</i><br /><i>GREM1</i><br />dup 15q13-q14&#x000a0;<sup>2</sup></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Adenomatous polyps, juvenile polyps, hyperplastic polyps, &#x00026; polyps containing mixed histology</div></li><li class="half_rhythm"><div>&#x02191; CRC risk&#x000a0;<sup>3</sup></div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Desmoid tumor, prostate cancer, &#x00026; duodenal adenocarcinoma reported in 1 individual&#x000a0;<sup>4</sup></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare condition (few families)</td></tr><tr><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sessile serrated polyposis syndrome<br />(OMIM <a href="https://omim.org/entry/617108" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617108</a>)</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RNF43</i></td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Sessile serrated polyps, serrated adenomas, or hyperplastic polyps of GI tract</div></li><li class="half_rhythm"><div>CRC risk: &#x02264;54%</div></li></ul>
</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown (various cancers reported in untested family members)</td><td headers="hd_h_maps.T.disorders_to_consider_in_the_diff_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare condition (few individuals)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; CHRPE = <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hypertrophy of the retinal pigment epithelium; CRC = colorectal cancer; FAP = <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> adenomatous polyposis; MAP = <i>MUTYH</i> polyposis; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; MSI = <a class="def" href="/books/n/gene/glossary/def-item/microsatellite/">microsatellite</a> instability</p></div></dd><dt>1. </dt><dd><div id="maps.TF.5.1"><p class="no_margin"><a class="bk_pop" href="#maps.REF.weren.2015.668">Weren et al [2015]</a>, <a class="bk_pop" href="#maps.REF.grolleman.2019.256">Grolleman et al [2019]</a></p></div></dd><dt>2. </dt><dd><div id="maps.TF.5.2"><p class="no_margin">Leads to overexpression of <i>GREM1</i></p></div></dd><dt>3. </dt><dd><div id="maps.TF.5.3"><p class="no_margin"><a class="bk_pop" href="#maps.REF.jaeger.2003.1261">Jaeger et al [2003]</a></p></div></dd><dt>4. </dt><dd><div id="maps.TF.5.4"><p class="no_margin"><a class="bk_pop" href="#maps.REF.lieberman.2017.1876">Lieberman et al [2017]</a></p></div></dd></dl></div></div></div></div><div id="maps.Management"><h2 id="_maps_Management_">Management</h2><div id="maps.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with <i>MUTYH</i> polyposis (MAP), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Review of personal medical history with emphasis on those features related to MAP or colorectal cancer (CRC): colon polyps (majority are adenomas), rectal bleeding, abdominal pain and discomfort, bloating, diarrhea</div></li><li class="half_rhythm"><div>Colonoscopy and review of pathology</div></li><li class="half_rhythm"><div>Baseline upper endoscopy including visualization of the major ampulla starting at age 30-35 years</div></li><li class="half_rhythm"><div>Baseline thyroid ultrasound examination [<a class="bk_pop" href="#maps.REF.laguardia.2011">LaGuardia et al 2011</a>]</div></li><li class="half_rhythm"><div>Consider skin examination by a dermatologist.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul><p>Currently, investigations for other extracolonic manifestations of MAP are not recommended at the time of initial diagnosis.</p></div><div id="maps.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Practice parameters, including information on surgery, have been outlined by the following resources:</p><ul><li class="half_rhythm"><div>National Comprehensive Cancer Network [<a class="bk_pop" href="#maps.REF50">NCCN 2019</a>]</div></li><li class="half_rhythm"><div>American College of Gastroenterology [<a class="bk_pop" href="#maps.REF.syngal.2015.223">Syngal et al 2015</a>] (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>)</div></li><li class="half_rhythm"><div>American Society of Colon and Rectal Surgeons [<a class="bk_pop" href="#maps.REF.church.2003.1001">Church et al 2003</a>]</div></li><li class="half_rhythm"><div>American Society of Clinical Oncology [<a class="bk_pop" href="#maps.REF.stoffel.2015.e437">Stoffel et al 2015</a>] (<a href="http://ascopubs.org/doi/full/10.1200/jop.2015.003665" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>)</div></li><li class="half_rhythm"><div>Society of Surgical Oncology [<a class="bk_pop" href="#maps.REF.guillem.2006.4642">Guillem et al 2006</a>] (<a href="http://jco.ascopubs.org/content/24/28/4642.abstract" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>)</div></li></ul><p><b>Colon polyps and colon cancer.</b> Surveillance guidelines for individuals with <i>MUTYH</i> polyposis are analogous to the guidelines for individuals with attenuated FAP. Colonoscopy and polypectomy is recommended every one to two years until polypectomy alone cannot manage the large size and density of the polyps, at which point colectomy may be necessary [<a class="bk_pop" href="#maps.REF.lipton.2006.221">Lipton &#x00026; Tomlinson 2006</a>, <a class="bk_pop" href="#maps.REF.sampson.2009.209">Sampson &#x00026; Jones 2009</a>]. Absolute indications for colectomy include documented or suspected CRC or significant symptoms (e.g., obstruction, bleeding), although these symptoms are uncommon in the absence of CRC. Relative indications for colectomy include presence of multiple adenomas &#x0003e;6 mm that cannot be reasonably managed by endoscopy, a significant increase in adenoma number between surveillance examinations, presence of adenomas with high-grade dysplasia, or inability to adequately survey the colon (e.g., due to innumerous diminutive adenomas or limited access to/compliance with colonoscopy) (see <a href="#maps.Surveillance">Surveillance</a>).</p><p>Types of colectomy include the following:</p><ul><li class="half_rhythm"><div>Proctocolectomy with ileal pouch anal anastomosis (IPAA), which can be performed laparoscopically, laparoscopically assisted, or open</div></li><li class="half_rhythm"><div>Total colectomy with ileorectal anastomosis (IRA)</div></li><li class="half_rhythm"><div>Total proctocolectomy with permanent ileostomy</div></li></ul><p>The choice of procedure depends on the clinical circumstances.</p><ul><li class="half_rhythm"><div>An IPAA is generally performed when the rectal polyp burden is high or as a second procedure after IRA when rectal disease burden cannot be managed endoscopically. The advantages of this procedure are near-elimination of risk for rectal cancer and relatively good preservation of bowel function. There may be an increased risk for bladder/sexual dysfunction and functional results can be variable.</div></li><li class="half_rhythm"><div>An IRA is generally considered when the rectal polyp burden is low and deemed to be endoscopically manageable. It is a technically straightforward procedure with low complication rates. It is usually associated with good functional outcome and minimizes risk for sexual or urinary dysfunction. This procedure should not be performed if there is severe rectal disease or the individual cannot reliably undergo endoscopic surveillance of the remaining rectum postoperatively.</div></li><li class="half_rhythm"><div>A total proctocolectomy with end ileostomy is almost never required unless a proctocolectomy is necessary (due to rectal polyp/cancer burden) and a contraindication to IPAA is present (e.g., a mesenteric desmoid preventing a pouch from reaching pelvic floor, low rectal cancer invading pelvic floor, or individual preference due to poor sphincter control).</div></li></ul><p><b>Duodenal polyps.</b> Management of polyps is similar to that in individuals with FAP. Endoscopic or surgical removal of duodenal and/or ampullary adenomas is recommended if polyps exhibit villous change or severe dysplasia, exceed 1 cm in diameter, or cause symptoms [<a class="bk_pop" href="#maps.REF.wallace.1998.742">Wallace &#x00026; Phillips 1998</a>, <a class="bk_pop" href="#maps.REF.saurin.1999.472">Saurin et al 1999</a>, <a class="bk_pop" href="#maps.REF.kadmon.2001.63">Kadmon et al 2001</a>]. Surgical options include a pancreas-sparing duodenectomy, which is a good option when the papilla is not involved and there is no suspicion for cancer. Pancreaticoduodenectomy (Whipple procedure) is associated with significantly higher morbidity; however, it must be considered if the duodenal papilla is involved or cancer is identified or strongly suspected.</p><p><b>Abnormal thyroid findings</b> should be evaluated by a thyroid specialist to determine the combination of monitoring, surgery, and/or fine needle aspiration that is appropriate [<a class="bk_pop" href="#maps.REF.laguardia.2011">LaGuardia et al 2011</a>].</p></div><div id="maps.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>For many individuals with MAP, colonic polyps are limited in number and surveillance with periodic colonoscopic polypectomy is sufficient to prevent CRC. Colonoscopy is therefore used for surveillance and prevention of CRC.</p><p>To reduce the risk for duodenal/periampullary adenocarcinoma, endoscopic or surgical removal of duodenal and/or ampullary adenomas should be considered if polyps exhibit villous change or severe dysplasia, exceed 1 cm in diameter, or cause symptoms.</p></div><div id="maps.Surveillance"><h3>Surveillance</h3><div id="maps.T.recommended_surveillance_for_indi" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>MUTYH</i> Polyposis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK107219/table/maps.T.recommended_surveillance_for_indi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__maps.T.recommended_surveillance_for_indi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Colon</b></td><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Colonoscopy w/polypectomy</td><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 1-2 yrs beginning at age 25-30 yrs&#x000a0;<sup>1,&#x000a0;2</sup></td></tr><tr><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Duodenum/Stomach</b></td><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Upper endoscopy &#x00026; side viewing duodenoscopy&#x000a0;<sup>3</sup></td><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 3 mos to 4 yrs beginning at age 30-35 yrs&#x000a0;<sup>1,&#x000a0;4</sup></td></tr><tr><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Extraintestinal malignancies</b></td><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider annual physical examination&#x000a0;<sup>5</sup>; may consider thyroid ultrasound&#x000a0;<sup>5</sup></td><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">May consider skin exam by dermatologist&#x000a0;<sup>5</sup></td><td headers="hd_h_maps.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">One time or annually</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="maps.TF.6.1"><p class="no_margin">Based on the US-based National Comprehensive Cancer Network (NCCN) guidelines [<a class="bk_pop" href="#maps.REF50">NCCN 2019</a>]</p></div></dd><dt>2. </dt><dd><div id="maps.TF.6.2"><p class="no_margin">If only small adenoma burden (&#x0003c;20 adenomas, &#x0003c;1 cm, and none with advanced histology [<a class="bk_pop" href="#maps.REF50">NCCN 2019</a>]), colonoscopy can be used to effectively eliminate polyps.</p></div></dd><dt>3. </dt><dd><div id="maps.TF.6.3"><p class="no_margin">Consider chromoendoscopy, which showed improved diagnostic yield in a recent study [<a class="bk_pop" href="#maps.REF.hurley.2018.665">Hurley et al 2018</a>].</p></div></dd><dt>4. </dt><dd><div id="maps.TF.6.4"><p class="no_margin">Based on findings using Spigelman Criteria [<a class="bk_pop" href="#maps.REF.spigelman.1989.783">Spigelman et al 1989</a>]</p></div></dd><dt>5. </dt><dd><div id="maps.TF.6.5"><p class="no_margin">Surveillance beyond existing protocols that are offered to the general population in most Western countries are not firmly recommended in the NCCN guidelines due to limited data.</p></div></dd></dl></div></div></div><div id="maps.Individuals_Heterozygous_for_a_Germ"><h4>Individuals Heterozygous for a Germline <i>MUTYH</i> Pathogenic Variant</h4><p>One published report on 62 <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> relatives of persons with MAP who were undergoing colonoscopy found that these persons could be at increased risk for neoplastic lesions compared to the general population, but that these results do not support intensive follow up. Therefore, <i>MUTYH</i> heterozygotes are expected to benefit from population screening measures but could also be offered average moderate-risk colorectal screening based on their family history.</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#maps.REF50">NCCN [2019]</a> guidelines propose that <i>MUTYH</i> heterozygotes with a <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> with CRC (who does not have MAP) undergo colonoscopy every five years beginning at age 40 years or ten years prior to the age of the first-degree relative's age at CRC diagnosis.</div></li><li class="half_rhythm"><div>For <i>MUTYH</i> heterozygotes with a <a class="def" href="/books/n/gene/glossary/def-item/second-degree-relative/">second-degree relative</a> with CRC or no family history of CRC, no screening advice is given due to inconclusive data.</div></li></ul></div></div><div id="maps.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Currently, no studies have investigated external factors or lifestyle factors that could affect the severity of the manifestations of <i>MUTYH</i> polyposis.</p><p>Smoking may affect polyp development based on a case report of monozygotic twins with MAP in which a somewhat more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was observed in the sister who smoked compared to her twin sister who did not smoke. While both twins had about 30 smaller low-grade adenomas, the twin sister who smoked also had three larger (6-10 mm) adenomas and one focal high-grade adenoma of 70 mm [<a class="bk_pop" href="#maps.REF.casper.2018.625">Casper et al 2018</a>].</p></div><div id="maps.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger sibs of an individual with MAP by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>MUTYH</i> pathogenic variants identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to reduce morbidity and mortality in those who would benefit from appropriate surveillance (beginning at age 10-15 years) and early identification and treatment of polyps.</p><p>See <a href="#maps.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="maps.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="maps.Genetic_Counseling"><h2 id="_maps_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="maps.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>MUTYH</i> polyposis (MAP) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="maps.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygous relatives of an individual with MAP are at a two- or at most threefold increased risk for late-onset colorectal cancer (CRC) (see Clinical Description, <a href="#maps.Heterozygotes">Heterozygotes</a>; <a href="#maps.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a>; and Surveillance, <a href="#maps.Individuals_Heterozygous_for_a_Germ">Individuals Heterozygous for a Germline <i>MUTYH</i> Pathogenic Variant</a>).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygous relatives of individuals with MAP are at a two- or, at most, threefold increased risk for late-onset CRC (see Clinical Description, <a href="#maps.Heterozygotes">Heterozygotes</a>; <a href="#maps.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a>; and Surveillance, <a href="#maps.Individuals_Heterozygous_for_a_Germ">Individuals Heterozygous for a Germline <i>MUTYH</i> Pathogenic Variant</a>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Unless the reproductive partner of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>), offspring will be obligate heterozygotes for a pathogenic variant in <i>MUTYH</i>.</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a>) frequency in the general northern European, Australian, and US population for a <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 1%-2% (see <a href="#maps.Prevalence">Prevalence</a>). Therefore, the risk to the offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and a reproductive partner of northern European, Australian, or US origin of having <i>MUTYH</i> polyposis is 0.5%-1.0%.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="maps.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>MUTYH</i> pathogenic variants in the family.</p><p>Reproductive partners of individuals with one or two <i>MUTYH</i> pathogenic variants can be offered <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to determine <i>MUTYH</i> <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status in order to clarify the risk for MAP in their offspring.</p></div><div id="maps.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#maps.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> when this has not been done before, to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or at risk of being carriers and to their reproductive partner to determine the risk of MAP in offspring (see <a href="#maps.Carrier_Heterozygote_Detection">Carrier Detection</a>).</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="maps.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>MUTYH</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> for MAP are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="maps.Resources"><h2 id="_maps_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Hereditary Colon Cancer Takes Guts</b></div><div><a href="http://www.hcctakesguts.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hcctakesguts.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=MUTYH-Associated%20Polyposis&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MUTYH-Associated Polyposis</a></div></li><li class="half_rhythm"><div><b>National Cancer Institute (NCI)</b></div><div>6116 Executive Boulevard</div><div>Suite 300</div><div>Bethesda MD 20892-8322</div><div><b>Phone:</b> 800-422-6237 (toll-free)</div><div><b>Email:</b> cancergovstaff@mail.nih.gov</div><div><a href="http://www.cancer.gov/cancertopics/pdq/genetics/colorectal/HealthProfessional/page1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Genetics of Colorectal Cancer (PDQ&#x000ae;)</a></div></li><li class="half_rhythm"><div><b>American Cancer Society (ACS)</b></div><div>250 Williams Street Northwest</div><div>Atlanta GA 30303</div><div><b>Phone:</b> 800-227-2345 (toll-free 24/7); 866-228-4327 (toll-free 24/7 TTY)</div><div><a href="http://www.cancer.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cancer.org</a></div></li><li class="half_rhythm"><div><b>Colon Cancer Alliance (CCA)</b></div><div>1200 G Street Northwest</div><div>Suite 800</div><div>Washington DC 20005</div><div><b>Phone:</b> 877-422-2030 (Toll-free Helpline); 202-434-8980</div><div><b>Fax:</b> 866-304-9075 (toll-free)</div><div><a href="http://www.ccalliance.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ccalliance.org</a></div></li><li class="half_rhythm"><div><b>United Ostomy Associations of America, Inc. (UOAA)</b></div><div>PO Box 66</div><div>Fairview TN 37062-0066</div><div><b>Phone:</b> 800-826-0826 (toll-free)</div><div><b>Email:</b> info@uoaa.org</div><div><a href="http://www.ostomy.org/Home.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ostomy.org</a></div></li></ul></div><div id="maps.Molecular_Genetics"><h2 id="_maps_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="maps.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>MUTYH Polyposis: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK107219/table/maps.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__maps.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_maps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_maps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_maps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_maps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_maps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_maps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_maps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4595" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MUTYH</i></a></td><td headers="hd_b_maps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4595" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p34<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_maps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UIF7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Adenine DNA glycosylase</a></td><td headers="hd_b_maps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.lovd.nl/MUTYH" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MUTYH homepage - Colon cancer gene variant databases</a></td><td headers="hd_b_maps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MUTYH" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MUTYH</a></td><td headers="hd_b_maps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MUTYH[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MUTYH</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="maps.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="maps.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for MUTYH Polyposis (<a href="/omim/604933,608456" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK107219/table/maps.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__maps.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604933" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604933</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MutY DNA GLYCOSYLASE; MUTYH</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608456" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608456</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FAMILIAL ADENOMATOUS POLYPOSIS 2; FAP2</td></tr></tbody></table></div></div><div id="maps.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>DNA base excision repair plays a critical role in DNA damage repair caused by ionizing radiation, various chemical oxidants, and reactive oxygen species. In humans, the most mutagenic species from oxidative damage is 8-oxo7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), which tends to mispair with adenine instead of the usual cytosine. This leads to G:C&#x0003e;T:A transversions in the DNA [<a class="bk_pop" href="#maps.REF.isidro.2004.353">Isidro et al 2004</a>].</p><p>The following enzymes work together in DNA base excision repair to prevent mutagenesis by DNA damage-produced 8-oxo-dG:</p><ul><li class="half_rhythm"><div>8-oxo-dGTPase (encoded by <i>NUDT1</i>): removes 8-oxo-dGTPs from the nucleotide pool to prevent incorporation into DNA</div></li><li class="half_rhythm"><div>N-glycosylase/DNA lyase (encoded by <i>OGG1</i>): detects and excises 8-oxo-dG adducts that have been misincorporated into DNA</div></li><li class="half_rhythm"><div>Adenine DNA glycosylase (encoded by <i>MUTYH)</i>: recognizes and excises misincorporated adenine bases to prevent G:C&#x0003e;T:A transversions from occurring</div></li></ul><p><b>Mechanism of disease causation.</b> A lack of functional adenine DNA glycosylase leads to accumulation of G:C&#x0003e;T:A transversions in daughter DNA strands post replication. Studies indicate that this transversion is common in colorectal tumor DNA from individuals with MAP. These pathogenic variants result in loss of adenine DNA glycosylase function [<a class="bk_pop" href="#maps.REF.lipton.2004.633">Lipton &#x00026; Tomlinson 2004</a>].</p><p><b><i>MUTYH</i>-specific laboratory technical considerations.</b>
<i>MUTYH</i> has multiple transcript variants encoding different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> (<a href="/gene/4595" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ncbi.nlm.nih.gov/gene/4595</a>). The isoforms differ in their N-terminus, which contains a mitochondrial localization signal (MLS). The putative nuclear localization signals (NLS) are located at both the N-terminus and C-terminus. The functional significance of the MLS and NLS in <i>MUTYH</i> is not entirely clear. Possibly they possess different glycosylase activity levels and/or have different expression levels in different tissues [<a class="bk_pop" href="#maps.REF.ma.2004.4332">Ma et al 2004</a>].</p><p>Following current <a href="http://www.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGVS</a> recommendations, a DNA reference sequence (<a href="/nuccore/NM_001128425.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001128425.1</a>) that is the longest possible transcript was created. Reported nucleotide and amino acid variants after nucleotide position 157 (amino acid 53) may differ by up to 42 nucleotides (14 amino acids). Care must be taken when searching the published literature for reported variants.</p><div id="maps.T.notable_mutyh_pathogenic_variants" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Notable <i>MUTYH</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK107219/table/maps.T.notable_mutyh_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__maps.T.notable_mutyh_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference<br />Sequences</th><th id="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide<br />Change</th><th id="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_1" rowspan="11" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001128425.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001128425<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001121897.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001121897<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.536A&#x0003e;G</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr179Cys<br />(p.Tyr165Cys)</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:top;">Common pathogenic variants carried by ~1%-2% of the general population that account for &#x02265;90% of all <i>MUTYH</i> pathogenic variants in northern European populations [<a class="bk_pop" href="#maps.REF.altassan.2002.227">Al-Tassan et al 2002</a>, <a class="bk_pop" href="#maps.REF.cleary.2009.1251">Cleary et al 2009</a>]; &#x02264;70% of persons w/MAP harbor at least 1 of these variants [<a class="bk_pop" href="#maps.REF.nielsen.2009b.471">Nielsen et al 2009b</a>].</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1187G&#x0003e;A</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly396Asp (p.Gly382Asp)</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.312C&#x0003e;A</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr104Ter</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Common in Pakistani population [<a class="bk_pop" href="#maps.REF.dolwani.2007.593">Dolwani et al 2007</a>, <a class="bk_pop" href="#maps.REF.khawaja.2007.s100">Khawaja &#x00026; Payne 2007</a>, <a class="bk_pop" href="#maps.REF.prior.2010">Prior &#x00026; Bridgeman 2010</a>]</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1118C&#x0003e;T</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala373Val</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:top;">Found in Japanese &#x00026; Korean populations [<a class="bk_pop" href="#maps.REF.kim.2007.1173">Kim et al 2007</a>, <a class="bk_pop" href="#maps.REF.yanarufujisawa.2008.545">Yanaru-Fujisawa et al 2008</a>]</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.857G&#x0003e;A</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly286Glu</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1147delC</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Common in northern European populations [<a class="bk_pop" href="#maps.REF.nielsen.2009b.471">Nielsen et al 2009b</a>]</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1214C&#x0003e;T</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro405Leu</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Common in the Dutch population [<a class="bk_pop" href="#maps.REF.nielsen.2005.e54">Nielsen et al 2005</a>]</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1227_1228dup</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Common in the Spanish, Portuguese, &#x00026; Tunisian populations [<a class="bk_pop" href="#maps.REF.g_mezfern_ndez.2009.57">G&#x000f3;mez-Fern&#x000e1;ndez et al 2009</a>, <a class="bk_pop" href="#maps.REF.abdelmaksouddammak.2012.503">Abdelmaksoud-Dammak et al 2012</a>]</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1437_1439del</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu480del</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Common in the Italian population [<a class="bk_pop" href="#maps.REF.gismondi.2004.680">Gismondi et al 2004</a>]</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1438G&#x0003e;T</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu480Ter</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Founder variant in the British Indian population [<a class="bk_pop" href="#maps.REF.dolwani.2007.593">Dolwani et al 2007</a>]</td></tr><tr><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Del exons 4-16</td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_maps.T.notable_mutyh_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Common in Spanish, Brazilian, &#x00026; French populations [<a class="bk_pop" href="#maps.REF.rouleau.2011.301">Rouleau et al 2011</a>, <a class="bk_pop" href="#maps.REF.torrezan.2011.128">Torrezan et al 2011</a>, <a class="bk_pop" href="#maps.REF.castillejo.2014.2241">Castillejo et al 2014</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="maps.TF.7.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div></div><div id="maps.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p>In general, MAP carcinomas somewhat mimic Lynch and <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> <a class="def" href="/books/n/gene/glossary/def-item/mismatch-repair/">mismatch repair</a> (MMR)-deficient tumors with a frequently proximal location in the colon and a high number of tumor-infiltrating lymphocytes (TILs) [<a class="bk_pop" href="#maps.REF.nielsen.2009a.184">Nielsen et al 2009a</a>]. Loss of HLA class I expression, a common event in Lynch tumors, was also found to be a frequent event in MAP carcinomas [<a class="bk_pop" href="#maps.REF.de_miranda.2009.69">de Miranda et al 2009</a>]. Also comparable to Lynch tumors, the majority of MAP carcinomas appear near-diploid, and <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> regions of copy-neutral <a class="def" href="/books/n/gene/glossary/def-item/loss-of-heterozygosity/">loss of heterozygosity</a> are frequent [<a class="bk_pop" href="#maps.REF.lipton.2003.7595">Lipton et al 2003</a>, <a class="bk_pop" href="#maps.REF.middeldorp.2008.25">Middeldorp et al 2008</a>].</p><p>Recent studies performed <a class="def" href="/books/n/gene/glossary/def-item/whole-exome-sequencing/">whole-exome sequencing</a> in MAP carcinomas and adenomas [<a class="bk_pop" href="#maps.REF.weren.2015.668">Weren et al 2015</a>, <a class="bk_pop" href="#maps.REF.rashid.2016.98">Rashid et al 2016</a>, <a class="bk_pop" href="#maps.REF.viel.2017.39">Viel et al 2017</a>]. In general, the combination of the excess G:C&#x0003e;T:A transversion and specific sequence context (transversions occurring preferentially in AGAA or TGAA motifs) led to assigning a novel mutational signature for MAP tumors, termed <i>signature 36</i> [<a class="bk_pop" href="#maps.REF.viel.2017.39">Viel et al 2017</a>].</p><p>The overall mutation rate in MAP carcinomas was estimated at approximately twofold higher than in <a class="def" href="/books/n/gene/glossary/def-item/microsatellite/">microsatellite</a>-stable (MSS) carcinomas &#x02013; in contrast to MSI CRCs, which are characterized by an almost tenfold increase over MSS carcinomas [<a class="bk_pop" href="#maps.REF.viel.2017.39">Viel et al 2017</a>]. A higher mutation load when comparing MAP with FAP tumors was found in adenomas from colon and duodenum as well [<a class="bk_pop" href="#maps.REF.rashid.2016.98">Rashid et al 2016</a>, <a class="bk_pop" href="#maps.REF.hurley.2018.665">Hurley et al 2018</a>]. The higher somatic mutation load in MAP tumors could cause a more activated immune system, comparable to that in Lynch/MMR-deficient colorectal tumors, and also indicates that tumors may be sensitive for immune therapies such as PD-1 blockade [<a class="bk_pop" href="#maps.REF.le.2015.2509">Le et al 2015</a>]. However, no such clinical research has been performed in individuals with MAP. Vaccine strategies now being developed could also be effective in MAP, but this also requires further research.</p></div></div><div id="maps.References"><h2 id="_maps_References_">References</h2><div id="maps.Published_Guidelines__Consensus_Sta"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="maps.REF1">NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines&#x02122;). Colorectal cancer screening. National Comprehensive Cancer Network, Inc. 2019.</div></li></ul></div><div id="maps.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="maps.REF.abdelmaksouddammak.2012.503">Abdelmaksoud-Dammak R, Miladi-Abdennadher I, Amouri A, Tahri N, Ayadi L, Khabir A, Frikha F, Gargouri A, Mokdad-Gargouri R. High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis. <span><span class="ref-journal">Fam Cancer. </span>2012;<span class="ref-vol">11</span>:503–8.</span> [<a href="/pubmed/22744763" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22744763</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.aim_.2015.390">Aim&#x000e9; A, Coulet F, Lefevre JH, Colas C, Cervera P, Flejou JF, Lascols O, Soubrier F, Parc Y. Somatic c.34G&#x0003e;T KRAS mutation: a new prescreening test for MUTYH-associated polyposis? <span><span class="ref-journal">Cancer Genet. </span>2015;<span class="ref-vol">208</span>:390–5.</span> [<a href="/pubmed/26056087" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26056087</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.altassan.2002.227">Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR, Cheadle JP. Inherited variants of MYH associated with somatic G:C--&#x0003e;T:A mutations in colorectal tumors. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">30</span>:227–32.</span> [<a href="/pubmed/11818965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11818965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.balaguer.2007.379">Balaguer F, Castellv&#x000ed;-Bel S, Castells A, Andreu M, Mu&#x000f1;oz J, Gisbert JP, Llor X, Jover R, de Cid R, Gonzalo V, Bessa X, Xicola RM, Pons E, Alenda C, Pay&#x000e1; A, Piqu&#x000e9; JM. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2007;<span class="ref-vol">5</span>:379–87.</span> [<a href="/pubmed/17368238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17368238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.banda.2017.202">Banda DM, Nu&#x000f1;ez NN, Burnside MA, Bradshaw KM, David SS. Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine. <span><span class="ref-journal">Free Radic Biol Med. </span>2017;<span class="ref-vol">107</span>:202–15.</span> [<a href="/pmc/articles/PMC5457711/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5457711</span></a>] [<a href="/pubmed/28087410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28087410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.baudhuin.2006.159">Baudhuin LM, Roberts LR, Enders FT, Swanson RL, Mettler TA, Aderca I, Stadheim LM, Highsmith WE. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients. <span><span class="ref-journal">J Cancer Res Clin Oncol. </span>2006;<span class="ref-vol">132</span>:159–62.</span> [<a href="/pubmed/16292541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16292541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.beiner.2009.575">Beiner ME, Zhang WW, Zhang S, Gallinger S, Sun P, Narod SA. Mutations of the MYH gene do not substantially contribute to the risk of breast cancer. <span><span class="ref-journal">Breast Cancer Res Treat. </span>2009;<span class="ref-vol">114</span>:575–8.</span> [<a href="/pubmed/18454351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18454351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.boparai.2008.2014">Boparai KS, Dekker E, Van Eeden S, Polak MM, Bartelsman JF, Mathus-Vliegen EM, Keller JJ, van Noesel CJ. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. <span><span class="ref-journal">Gastroenterology. </span>2008;<span class="ref-vol">135</span>:2014–8.</span> [<a href="/pubmed/19013464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19013464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.casper.2018.625">Casper M, Spier I, Holz R, Aretz S, Lammert F. Phenotypic Variability of MUTYH-Associated Polyposis in Monozygotic Twins and Endoscopic Resection of A Giant Polyp in Pregnancy. <span><span class="ref-journal">Am J Gastroenterol. </span>2018;<span class="ref-vol">113</span>:625–7.</span> [<a href="/pubmed/29610499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29610499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.castillejo.2014.2241">Castillejo A, Vargas G, Castillejo MI, Navarro M, Barber&#x000e1; VM, Gonz&#x000e1;lez S, Hern&#x000e1;ndez-Ill&#x000e1;n E, Brunet J, Ram&#x000f3;n y Cajal T, Balma&#x000f1;a J, Oltra S, Iglesias S, Velasco A, Solanes A, Campos O, S&#x000e1;nchez Heras AB, Gallego J, Carrasco E, Gonz&#x000e1;lez Juan D, Segura A, Chirivella I, Juan MJ, Tena I, L&#x000e1;zaro C, Blanco I, Pineda M, Capell&#x000e1; G, Soto JL. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients. <span><span class="ref-journal">Eur J Cancer. </span>2014;<span class="ref-vol">50</span>:2241–50.</span> [<a href="/pubmed/24953332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24953332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.chow.2006.30">Chow E, Lipton L, Lynch E, D'Souza R, Aragona C, Hodgkin L, Brown G, Winship I, Barker M, Buchanan D, Cowie S, Nasioulas S, du Sart D, Young J, Leggett B, Jass J, Macrae F. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. <span><span class="ref-journal">Gastroenterology. </span>2006;<span class="ref-vol">131</span>:30–9.</span> [<a href="/pubmed/16831587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16831587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.church.2016.565">Church J, Kravochuck S. The "studded" rectum: phenotypic evidence of MYH-associated polyposis. <span><span class="ref-journal">Dis Colon Rectum. </span>2016;<span class="ref-vol">59</span>:565–9.</span> [<a href="/pubmed/27145315" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27145315</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.church.2003.1001">Church J, Simmang C, et al.  Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). <span><span class="ref-journal">Dis Colon Rectum. </span>2003;<span class="ref-vol">46</span>:1001–12.</span> [<a href="/pubmed/12907889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12907889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.cleary.2009.1251">Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N, Parfrey P, Potter J, Younghusband B, Gallinger S. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. <span><span class="ref-journal">Gastroenterology. </span>2009;<span class="ref-vol">136</span>:1251–60.</span> [<a href="/pmc/articles/PMC2739726/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2739726</span></a>] [<a href="/pubmed/19245865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19245865</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.croitoru.2004.1631">Croitoru ME, Cleary SP, Di Nicola N, Manno M, Selander T, Aronson M, Redston M, Cotterchio M, Knight J, Gryfe R, Gallinger S. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. <span><span class="ref-journal">JNCI. </span>2004;<span class="ref-vol">96</span>:1631–4.</span> [<a href="/pubmed/15523092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15523092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.de_miranda.2009.69">de Miranda NF, Nielsen M, Pereira D, van Puijenbroek M, Vasen HF, Hes FJ, van Wezel T, Morreau H. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers. <span><span class="ref-journal">J Pathol. </span>2009;<span class="ref-vol">219</span>:69–76.</span> [<a href="/pubmed/19462419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19462419</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.dolwani.2007.593">Dolwani S, Williams GT, West KP, Newman J, Stock D, Griffiths AP, Best J, Cheadle JP, Sampson JR. Analysis of inherited MYH/(MutYH) mutations in British Asian patients with colorectal cancer. <span><span class="ref-journal">Gut. </span>2007;<span class="ref-vol">56</span>:593.</span> [<a href="/pmc/articles/PMC1856848/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1856848</span></a>] [<a href="/pubmed/17369389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17369389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.dumanski.2017.427">Dumanski JP, Rasi C, Bj&#x000f6;rklund P, Davies H, Ali AS, Gr&#x000f6;nberg M, Welin S, Sorbye H, Gr&#x000f8;nb&#x000e6;k H, Cunningham JL, Forsberg LA, Lind L, Ingelsson E, St&#x000e5;lberg P, Hellman P, Tiensuu Janson E. A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors. <span><span class="ref-journal">Endocr Relat Cancer. </span>2017;<span class="ref-vol">24</span>:427–43.</span> [<a href="/pmc/articles/PMC5527373/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5527373</span></a>] [<a href="/pubmed/28634180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28634180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.el_hachem.2019.470">El Hachem N, Abadie C, Longy M, Colas C, Fert-Ferrer S, Leroux D, Grandval P, Prieur F, Collonge-Rame M, Faivre L, Fricker JP, Zerbib F, Coupier I, Cauchin E, Pinson S, Saurin JC. Endoscopic phenotype of monoallelic carriers of MUTYH gene mutations in the family of polyposis patients: a prospective study. <span><span class="ref-journal">Dis Colon Rectum. </span>2019;<span class="ref-vol">62</span>:470–5.</span> [<a href="/pubmed/30640315" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30640315</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.farrington.2005.112">Farrington SM, Tenesa A, Barnetson R, Wiltshire A, Prendergast J, Porteous M, Campbell H, Dunlop M. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">77</span>:112–9.</span> [<a href="/pmc/articles/PMC1226182/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226182</span></a>] [<a href="/pubmed/15931596" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15931596</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.fulk.2019.197">Fulk K, LaDuca H, Black MH, Qian D, Tian Y, Yussuf A, Espenschied C, Jasperson K. Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort. <span><span class="ref-journal">Fam Cancer. </span>2019;<span class="ref-vol">18</span>:197–201.</span> [<a href="/pubmed/30582135" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30582135</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.gismondi.2004.680">Gismondi V, Meta M, Bonelli L, Radice P, Sala P, Bertario L, Viel A, Fornasarig M, Arrigoni A, Gentile M, Ponz de Leon M, Anselmi L, Mareni C, Bruzzi P, Varesco L. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. <span><span class="ref-journal">Int J Cancer. </span>2004;<span class="ref-vol">109</span>:680–4.</span> [<a href="/pubmed/14999774" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14999774</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.g_mezfern_ndez.2009.57">G&#x000f3;mez-Fern&#x000e1;ndez N, Castellv&#x000ed;-Bel S, Fern&#x000e1;ndez-Rozadilla C, Balaguer F, Mu&#x000f1;oz J, Madrigal I, Mil&#x000e0; M, Gra&#x000f1;a B, Vega A, Castells A, Carracedo A, Ruiz-Ponte C. Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations? <span><span class="ref-journal">BMC Med Genet. </span>2009;<span class="ref-vol">10</span>:57.</span> [<a href="/pmc/articles/PMC2702373/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2702373</span></a>] [<a href="/pubmed/19531215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19531215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.grolleman.2019.256">Grolleman JE, de Voer RM, Elsayed FA, Nielsen M, Weren RDA, Palles C, Ligtenberg MJL, Vos JR, Ten Broeke SW, de Miranda NFCC, Kuiper RA, Kamping EJ, Jansen EAM, Vink-B&#x000f6;rger ME, Popp I, Lang A, Spier I, H&#x000fc;neburg R, James PA, Li N, Staninova M, Lindsay H, Cockburn D, Spasic-Boskovic O, Clendenning M, Sweet K, Capell&#x000e1; G, Sjursen W, H&#x000f8;berg-Vetti H, Jongmans MC, Neveling K, Geurts van Kessel A, Morreau H, Hes FJ, Sijmons RH, Schackert HK, Ruiz-Ponte C, Dymerska D, Lubinski J, Rivera B, Foulkes WD, Tomlinson IP, Valle L, Buchanan DD, Kenwrick S, Adlard J, Dimovski AJ, Campbell IG, Aretz S, Schindler D, van Wezel T, Hoogerbrugge N, Kuiper RP. Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype. <span><span class="ref-journal">Cancer Cell. </span>2019;<span class="ref-vol">35</span>:256–66.e5.</span> [<a href="/pubmed/30753826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30753826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.grover.2012.485">Grover S, Kastrinos F, Steyerberg EW, Cook EF, Dewanwala A, Burbidge LA, Wenstrup RJ, Syngal S. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. <span><span class="ref-journal">JAMA. </span>2012;<span class="ref-vol">308</span>:485–92.</span> [<a href="/pmc/articles/PMC3770297/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3770297</span></a>] [<a href="/pubmed/22851115" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22851115</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.guarinos.2014.1158">Guarinos C, Ju&#x000e1;rez M, Egoavil C, Rodr&#x000ed;guez-Soler M, P&#x000e9;rez-Carbonell L, Salas R, Cubiella J, Rodr&#x000ed;guez-Moranta F, de-Castro L, Bujanda L, Serradesanferm A, Nicol&#x000e1;s-P&#x000e9;rez D, Herr&#x000e1;iz M, Fern&#x000e1;ndez-Ba&#x000f1;ares F, Herreros-de-Tejada A, Aguirre E, Balma&#x000f1;a J, Rinc&#x000f3;n ML, Pizarro A, Polo-Ortiz F, Castillejo A, Alenda C, Pay&#x000e1; A, Soto JL, Jover R. Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps. <span><span class="ref-journal">Clin Cancer Res. </span>2014;<span class="ref-vol">20</span>:1158–68.</span> [<a href="/pubmed/24470512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24470512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.guillem.2006.4642">Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, Giardiello F, Rodriguez-Bigas MA, Church J, Gruber S, Offit K, et al.  ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. <span><span class="ref-journal">J Clin Oncol. </span>2006;<span class="ref-vol">24</span>:4642–60.</span> [<a href="/pubmed/17008706" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17008706</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.hurley.2018.665">Hurley JJ, Thomas LE, Walton SJ, Thomas-Gibson S, Haycock A, Suzuki N, Mort M, Williams G, Morgan M, Clark SK, Sampson JR, Dolwani S. The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis. <span><span class="ref-journal">Gastrointest Endosc. </span>2018;<span class="ref-vol">88</span>:665–73.</span> [<a href="/pubmed/29702101" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29702101</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.isidro.2004.353">Isidro G, Laranjeira F, Pires A, Leite J, Regateiro F, Castro e Sousa F, Soares J, Castro C, Giria J, Brito MJ, Medeira A, Teixeira R, Morna H, Gaspar I, Marinho C, Jorge R, Brehm A, Ramos JS, Boavida MG. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">24</span>:353–4.</span> [<a href="/pubmed/15366000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15366000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.jaeger.2003.1261">Jaeger EE, Woodford-Richens KL, Lockett M, Rowan AJ, Sawyer EJ, Heinimann K, Rozen P, Murday VA, Whitelaw SC, Ginsberg A, Atkin WS, Lynch HT, Southey MC, Debinski H, Eng C, Bodmer WF, Talbot IC, Hodgson SV, Thomas HJ, Tomlinson IP. An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:1261–7.</span> [<a href="/pmc/articles/PMC1180277/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180277</span></a>] [<a href="/pubmed/12696020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12696020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.jenkins.2006.312">Jenkins MA, Croitoru ME, Monga N, Cleary SP, Cotterchio M, Hopper JL, Gallinger S. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2006;<span class="ref-vol">15</span>:312–4.</span> [<a href="/pubmed/16492921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16492921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.jones.2009.489">Jones N, Vogt S, Nielsen M, Christian D, Wark PA, Eccles D, Edwards E, Evans DG, Maher ER, Vasen HF, Hes FJ, Aretz S, Sampson JR. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. <span><span class="ref-journal">Gastroenterology. </span>2009;<span class="ref-vol">137</span>:489–94.</span> [<a href="/pubmed/19394335" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19394335</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.kadmon.2001.63">Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. <span><span class="ref-journal">Int J Colorectal Dis. </span>2001;<span class="ref-vol">16</span>:63–75.</span> [<a href="/pubmed/11355321" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11355321</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.kallenberg.2017.1057">Kallenberg FGJ, Bastiaansen BAJ, Nio CY, Soeters MR, Boermeester MA, Aalfs CM, Bossuyt PMM, Dekker E. Adrenal Lesions in Patients With (Attenuated) Familial Adenomatous Polyposis and MUTYH-Associated Polyposis. <span><span class="ref-journal">Dis Colon Rectum. </span>2017;<span class="ref-vol">60</span>:1057–64.</span> [<a href="/pubmed/28891849" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28891849</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.khawaja.2007.s100">Khawaja F, Payne SJ. The E447X MYH mutation is a major contributor to inherited colorectal cancer in the Gujurati population. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:S100.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.kim.2007.1173">Kim DW, Kim IJ, Kang HC, Jang SG, Kim K, Yoon HJ, Ahn SA, Han SY, Hong SH, Hwang JA, Sohn DK, Jeong SY, Choi HS, Hong CW, Lim SB, Park JG. Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas. <span><span class="ref-journal">Int J Colorectal Dis. </span>2007;<span class="ref-vol">22</span>:1173–8.</span> [<a href="/pubmed/17703316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17703316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.laduca.2019">LaDuca H, Polley EC, Yussuf A, Hoang L, Gutierrez S, Hart SN, Yadav S, Hu C, Na J, Goldgar DE, Fulk K, Smith LP, Horton C, Profato J, Pesaran T, Gau CL, Pronold M, Davis BT, Chao EC, Couch FJ, Dolinsky JS. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. <span><span class="ref-journal">Genet Med. </span>2019.</span> Epub ahead of print. [<a href="/pubmed/31406321" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31406321</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.laguardia.2011">LaGuardia L, O'Malley M, Milas M, Burke C, Kalady M, Church J, Weiss SR. Cleveland Clinic study: Uncovering the hidden risk of thyroid cancer in MYH-associated polyposis. Abstract 12. Montreal, Canada: 15th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer. 2011.</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.landon.2015.368">Landon M, Ceulemans S, Saraiya DS, Strike B, Arnell C, Burbidge LA, Moyes K, Theisen A, Fernandes PH, Ji JQ, Abbott B, Kaldate RR, Roa B. Analysis of current testing practices for biallelic MUTYH mutations in MUTYH-associated polyposis. <span><span class="ref-journal">Clin Genet. </span>2015;<span class="ref-vol">87</span>:368–72.</span> [<a href="/pubmed/24620956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24620956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.le.2015.2509">Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. <span><span class="ref-journal">N Engl J Med. </span>2015;<span class="ref-vol">372</span>:2509–20.</span> [<a href="/pmc/articles/PMC4481136/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4481136</span></a>] [<a href="/pubmed/26028255" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26028255</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.lieberman.2017.1876">Lieberman S, Walsh T, Schechter M, Adar T, Goldin E, Beeri R, Sharon N, Baris H, Ben Avi L, Half E, Lerer I, Shirts BH, Pritchard CC, Tomlinson I, King MC, Levy-Lahad E, Peretz T, Goldberg Y. Features of patients with hereditary mixed polyposis syndrome caused by duplication of GREM1 and Implications for Screening and Surveillance. <span><span class="ref-journal">Gastroenterology. </span>2017;<span class="ref-vol">152</span>:1876–80.e1.</span> [<a href="/pubmed/28242209" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28242209</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.lipton.2003.7595">Lipton L, Halford SE, Johnson V, Novelli M, Jones A, Cummings C, Barclay E, Sieber O, Sadat A, Bisgaard M, Hodgson S, Aaltonen L, Thomas H, Tomlinson I. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. <span><span class="ref-journal">Cancer Res. </span>2003;<span class="ref-vol">63</span>:7595–9.</span> [<a href="/pubmed/14633673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14633673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.lipton.2006.221">Lipton L, Tomlinson I. The genetics of FAP and FAP-like syndromes. <span><span class="ref-journal">Fam Cancer. </span>2006;<span class="ref-vol">5</span>:221–6.</span> [<a href="/pubmed/16998667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16998667</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.lipton.2004.633">Lipton L, Tomlinson I. The multiple colorectal adenoma phenotype and MYH, a base excision repair gene. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2004;<span class="ref-vol">2</span>:633–8.</span> [<a href="/pubmed/15290654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15290654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.lubbe.2009.3975">Lubbe SJ, Di Bernardo MC, Chandler IP, Houlston RS. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. <span><span class="ref-journal">J Clin Oncol. </span>2009;<span class="ref-vol">27</span>:3975–80.</span> [<a href="/pubmed/19620482" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19620482</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.ma.2004.4332">Ma H, Lee HM, Englander EW. N-terminus of the rat adenine glycosylase MYH affects excision rates and processing of MYH-generated abasic sites. <span><span class="ref-journal">Nucleic Acids Res. </span>2004;<span class="ref-vol">32</span>:4332–9.</span> [<a href="/pmc/articles/PMC514379/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC514379</span></a>] [<a href="/pubmed/15310837" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15310837</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.middeldorp.2008.25">Middeldorp A, van Puijenbroek M, Nielsen M, Corver WE, Jordanova ES, ter Haar N, Tops CM, Vasen HF, Lips EH, van Eijk R, Hes FJ, Oosting J, Wijnen J, van Wezel T, Morreau H. High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas. <span><span class="ref-journal">J Pathol. </span>2008;<span class="ref-vol">216</span>:25–31.</span> [<a href="/pubmed/18506705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18506705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.morak.2010.353">Morak M, Laner A, Nacher U, Keiling C, Holinski-Feder E. MUTYH-associated polyposis &#x02013; variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations. <span><span class="ref-journal">Clin Genet. </span>2010;<span class="ref-vol">78</span>:353–63.</span> [<a href="/pubmed/20618354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20618354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF50">NCCN (2019) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines&#x02122;). Colorectal cancer screening. National Comprehensive Cancer Network, Inc.</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.nielsen.2009a.184">Nielsen M, de Miranda NF, van Puijenbroek M, Jordanova ES, Middeldorp A, van Wezel T, van Eijk R, Tops CM, Vasen HF, Hes FJ, Morreau H. Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas. <span><span class="ref-journal">BMC Cancer. </span>2009a;<span class="ref-vol">9</span>:184.</span> [<a href="/pmc/articles/PMC2706846/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2706846</span></a>] [<a href="/pubmed/19527492" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19527492</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.nielsen.2005.e54">Nielsen M, Franken PF, Reinards TH, Weiss MM, Wagner A, van der Klift H, Kloosterman S, Houwing-Duistermaat JJ, Aalfs CM, Ausems MG, Br&#x000f6;cker-Vriends AH, Gomez Garcia EB, Hoogerbrugge N, Menko FH, Sijmons RH, Verhoef S, Kuipers EJ, Morreau H, Breuning MH, Tops CM, Wijnen JT, Vasen HF, Fodde R, Hes FJ. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:e54</span> [<a href="/pmc/articles/PMC1736132/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736132</span></a>] [<a href="/pubmed/16140997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16140997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.nielsen.2009b.471">Nielsen M, Joerink-van de Beld MC, Jones N, Vogt S, Tops CM, Vasen HF, Sampson JR, Aretz S, Hes FJ. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. <span><span class="ref-journal">Gastroenterology. </span>2009b;<span class="ref-vol">136</span>:471–6.</span> [<a href="/pubmed/19032956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19032956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.nielsen.2011.1">Nielsen M, Morreau H, Vasen HF, Hes FJ. MUTYH-associated polyposis (MAP). <span><span class="ref-journal">Crit Rev Oncol Hematol. </span>2011;<span class="ref-vol">79</span>:1–16.</span> [<a href="/pubmed/20663686" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20663686</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.nielsen.2006.1212">Nielsen M, Poley JW, Verhoef S, van Puijenbroek M, Weiss MM, Burger GT, Dommering CJ, Vasen HF, Kuipers EJ, Wagner A, Morreau H, Hes FJ. Duodenal carcinoma in MUTYH-associated polyposis. <span><span class="ref-journal">J Clin Pathol. </span>2006;<span class="ref-vol">59</span>:1212–5.</span> [<a href="/pmc/articles/PMC1860523/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1860523</span></a>] [<a href="/pubmed/16943222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16943222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.nielsen.2010.1724">Nielsen M, van Steenbergen LN, Jones N, Vogt S, Vasen HF, Morreau H, Aretz S, Sampson JR, Dekkers OM, Janssen-Heijnen ML, Hes FJ. Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patients. <span><span class="ref-journal">J Natl Cancer Inst. </span>2010;<span class="ref-vol">102</span>:1724–30.</span> [<a href="/pmc/articles/PMC2982808/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2982808</span></a>] [<a href="/pubmed/21044966" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21044966</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.oshea.2008.184">O'Shea AM, Cleary SP, Croitoru MA, Kim H, Berk T, Monga N, Riddell RH, Pollett A, Gallinger S. Pathological features of colorectal carcinomas in MYH-associated polyposis. <span><span class="ref-journal">Histopathology. </span>2008;<span class="ref-vol">53</span>:184–94.</span> [<a href="/pmc/articles/PMC2754312/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2754312</span></a>] [<a href="/pubmed/18564191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18564191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.out.2010.1205">Out AA, Tops CM, Nielsen M, Weiss MM, van Minderhout IJ, Fokkema IF, Buisine MP, Claes K, Colas C, Fodde R, Fostira F, Franken PF, Gaustadnes M, Heinimann K, Hodgson SV, Hogervorst FB, Holinski-Feder E, Lagerstedt-Robinson K, Olschwang S, van den Ouweland AM, Redeker EJ, Scott RJ, Vankeirsbilck B, Gr&#x000f8;nlund RV, Wijnen JT, Wikman FP, Aretz S, Sampson JR, Devilee P, den Dunnen JT, Hes FJ. Leiden Open Variation Database of the MUTYH gene. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:1205–15.</span> [<a href="/pubmed/20725929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20725929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.out.2012.219">Out AA, Wasielewski M, Huijts PE, van Minderhout IJ, Houwing-Duistermaat JJ, Tops CM, Nielsen M, Seynaeve C, Wijnen JT, Breuning MH, van Asperen CJ, Schutte M, Hes FJ, Devilee P. MUTYH gene variants and breast cancer in a Dutch case&#x02013;control study. <span><span class="ref-journal">Breast Cancer Res Treat. </span>2012;<span class="ref-vol">134</span>:219–27.</span> [<a href="/pmc/articles/PMC3397219/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3397219</span></a>] [<a href="/pubmed/22297469" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22297469</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.pearlman.2017.464">Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, Bacher J, Bigley C, Nelsen L, Goodfellow PJ, et al.  Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. <span><span class="ref-journal">JAMA Oncol. </span>2017;<span class="ref-vol">3</span>:464–71.</span> [<a href="/pmc/articles/PMC5564179/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5564179</span></a>] [<a href="/pubmed/27978560" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27978560</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.pilati.2017.10">Pilati C, Shinde J, Alexandrov LB, Assi&#x000e9; G, Andr&#x000e9; T, H&#x000e9;lias-Rodzewicz Z, Ducoudray R, Le Corre D, Zucman-Rossi J, Emile JF, Bertherat J, Letouz&#x000e9; E, Laurent-Puig P. Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas. <span><span class="ref-journal">J Pathol. </span>2017;<span class="ref-vol">242</span>:10–15.</span> [<a href="/pubmed/28127763" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28127763</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.prior.2010">Prior TW, Bridgeman SJ. Identifying mutations for MYH-associated polyposis. In: Haines JL, Korf BR, Morton CC, Seidman CE, Seidman JG, Smith DR, eds. <em>Current Protocols in Human Genetics.</em> Suppl 64. New York, NY: John Wiley &#x00026; Sons; 2010:10-13.</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.rashid.2016.98">Rashid M, Fischer A, Wilson CH, Tiffen J, Rust AG, Stevens P, Idziaszczyk S, Maynard J, Williams GT, Mustonen V, Sampson JR, Adams DJ. Adenoma development in familial adenomatous polyposis and MUTYH-associated polyposis: somatic landscape and driver genes. <span><span class="ref-journal">J Pathol. </span>2016;<span class="ref-vol">238</span>:98–108.</span> [<a href="/pmc/articles/PMC4832337/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4832337</span></a>] [<a href="/pubmed/26414517" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26414517</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.ricci.2017.309">Ricci MT, Miccoli S, Turchetti D, Bondavalli D, Viel A, Quaia M, Giacomini E, Gismondi V, Sanchez-Mete L, Stigliano V, Martayan A, Mazzei F, Bignami M, Bonelli L, Varesco L. Type and frequency of MUTYH variants in Italian patients with suspected MAP: a retrospective multicenter study. <span><span class="ref-journal">J Hum Genet. </span>2017;<span class="ref-vol">62</span>:309–15.</span> [<a href="/pubmed/27829682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27829682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.rizzolo.2018.583">Rizzolo P, Silvestri V, Bucalo A, Zelli V, Valentini V, Catucci I, Zanna I, Masala G, Bianchi S, Spinelli AM, Tommasi S, Tibiletti MG, Russo A, Varesco L, Coppa A, Calistri D, Cortesi L, Viel A, Bonanni B, Azzollini J, Manoukian S, Montagna M, Radice P, Palli D, Peterlongo P, Ottini L. Contribution of MUTYH variants to male breast cancer risk: results from a multicenter study in Italy. <span><span class="ref-journal">Front Oncol. </span>2018;<span class="ref-vol">8</span>:583.</span> [<a href="/pmc/articles/PMC6288482/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6288482</span></a>] [<a href="/pubmed/30564557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30564557</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.rouleau.2011.301">Rouleau E, Zattara H, Lefol C, Noguchi T, Briaux A, Buecher B, Bourdon V, Sobol H, Lidereau R, Olschwang S. First large rearrangement in the MUTYH gene and attenuated familial adenomatous polyposis syndrome. <span><span class="ref-journal">Clin Genet. </span>2011;<span class="ref-vol">80</span>:301–3.</span> [<a href="/pubmed/21815886" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21815886</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.sampson.2009.209">Sampson JR, Jones N. MUTYH-associated polyposis. <span><span class="ref-journal">Best Pract Res Clin Gastroenterol. </span>2009;<span class="ref-vol">23</span>:209–18.</span> [<a href="/pubmed/19414147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19414147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.saurin.1999.472">Saurin JC, Chayvialle JA, Ponchon T. Management of duodenal adenomas in familial adenomatous polyposis. <span><span class="ref-journal">Endoscopy. </span>1999;<span class="ref-vol">31</span>:472–8.</span> [<a href="/pubmed/10494690" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10494690</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.scarpa.2017.65">Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, et al.  Whole-genome landscape of pancreatic neuroendocrine tumours. <span><span class="ref-journal">Nature. </span>2017;<span class="ref-vol">543</span>:65–71.</span> [<a href="/pubmed/28199314" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28199314</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.sieber.2003.791">Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK, Bisgaard ML, Orntoft TF, Aaltonen LA, Hodgson SV, Thomas HJ, Tomlinson IP. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:791–9.</span> [<a href="/pubmed/12606733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12606733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.spigelman.1989.783">Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. <span><span class="ref-journal">Lancet. </span>1989;<span class="ref-vol">2</span>:783–5.</span> [<a href="/pubmed/2571019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2571019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.stanich.2019.2008">Stanich PP, Pearlman R, Hinton A, Gutierrez S, LaDuca H, Hampel H, Jasperson K. Prevalence of germline mutations in polyposis and colorectal cancer-associated genes in patients with multiple colorectal polyps. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2019;<span class="ref-vol">17</span>:2008–15.e3.</span> [<a href="/pubmed/30557735" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30557735</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.stoffel.2015.e437">Stoffel EM, Mangu PB, Limburg PJ, et al.  Hereditary colorectal cancer syndromes: American Society of Clinical Oncology clinical practice guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology clinical practice guidelines. <span><span class="ref-journal">J Oncol Pract. </span>2015;<span class="ref-vol">11</span>:e437–41.</span> [<a href="/pubmed/25829526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25829526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.sutcliffe.2019.203">Sutcliffe EG, Bartenbaker Thompson A, Stettner AR, Marshall ML, Roberts ME, Susswein LR, Wang Y, Klein RT, Hruska KS, Solomon BD. Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis. <span><span class="ref-journal">Fam Cancer. </span>2019;<span class="ref-vol">18</span>:203–9.</span> [<a href="/pubmed/30604180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30604180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.syngal.2015.223">Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al.  ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. <span><span class="ref-journal">Am J Gastroenterol. </span>2015;<span class="ref-vol">110</span>:223–62.</span> [<a href="/pmc/articles/PMC4695986/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4695986</span></a>] [<a href="/pubmed/25645574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25645574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.terdiman.2009.1883">Terdiman JP. MYH-associated disease: attenuated adenomatous polyposis of the colon is only part of the story. <span><span class="ref-journal">Gastroenterology. </span>2009;<span class="ref-vol">137</span>:1883–6.</span> [<a href="/pubmed/19879216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19879216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.terlouw.2019">Terlouw D, Suerink M, Singh SS, Gille HJJP, Hes FJ, Langers AMJ, Morreau H, Vasen HFA, Vos YJ, van Wezel T, Tops CM, Ten Broeke SW, Nielsen M. Declining detection rates for APC and biallelic MUTYH variants in polyposis patients, implications for DNA testing policy. <span><span class="ref-journal">Eur J Hum Genet. </span>2019.</span> Epub ahead of print. [<a href="/pubmed/31527860" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31527860</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.torrezan.2011.128">Torrezan GT, da Silva FC, Krepischi AC, Santos &#x000c9;M, Ferreira Fde O, Rossi BM, Carraro DM. Breakpoint characterization of a novel large intragenic deletion of MUTYH detected in a MAP patient: case report. <span><span class="ref-journal">BMC Med Genet. </span>2011;<span class="ref-vol">12</span>:128.</span> [<a href="/pmc/articles/PMC3203034/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3203034</span></a>] [<a href="/pubmed/21962078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21962078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.van_puijenbroek.2008.139">van Puijenbroek M, Nielsen M, Tops CM, Halfwerk H, Vasen HF, Weiss MM, van Wezel T, Hes FJ, Morreau H. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G&#x0003e;T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. <span><span class="ref-journal">Clin Cancer Res. </span>2008;<span class="ref-vol">14</span>:139–42.</span> [<a href="/pubmed/18172263" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18172263</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.viel.2017.39">Viel A, Bruselles A, Meccia E, Fornasarig M, Quaia M, Canzonieri V, Policicchio E, Urso ED, Agostini M, Genuardi M, Lucci-Cordisco E, Venesio T, Martayan A, Diodoro MG, Sanchez-Mete L, Stigliano V, Mazzei F, Grasso F, Giuliani A, Baiocchi M, Maestro R, Giannini G, Tartaglia M, Alexandrov LB, Bignami M. A specific mutational signature associated with DNA 8-oxoguanine persistence in MUTYH-defective colorectal cancer. <span><span class="ref-journal">EBioMedicine. </span>2017;<span class="ref-vol">20</span>:39–49.</span> [<a href="/pmc/articles/PMC5478212/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5478212</span></a>] [<a href="/pubmed/28551381" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28551381</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.vogt.2009">Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, Steinke V, Vasen HF, Propping P, Sampson JR, Hes FJ, Aretz S. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009; 137:1976-85.e1-10. [<a href="/pubmed/19732775" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19732775</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.wallace.1998.742">Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. <span><span class="ref-journal">Br J Surg. </span>1998;<span class="ref-vol">85</span>:742–50.</span> [<a href="/pubmed/9667698" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9667698</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.walton.2016.986">Walton SJ, Kallenberg FG, Clark SK, Dekker E, Latchford A. Frequency and Features of Duodenal Adenomas in Patients With MUTYH-Associated Polyposis. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2016;<span class="ref-vol">14</span>:986–92.</span> [<a href="/pubmed/26905905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26905905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.weren.2015.668">Weren RD, Ligtenberg MJ, Kets CM, de Voer RM, Verwiel ET, Spruijt L, van Zelst-Stams WA, Jongmans MC, Gilissen C, Hehir-Kwa JY, Hoischen A, Shendure J, Boyle EA, Kamping EJ, Nagtegaal ID, Tops BB, Nagengast FM, Geurts van Kessel A, van Krieken JH, Kuiper RP, Hoogerbrugge N. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. <span><span class="ref-journal">Nat Genet. </span>2015;<span class="ref-vol">47</span>:668–71.</span> [<a href="/pubmed/25938944" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25938944</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.win.2014">Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG, Boussioutas A, Macrae FA, Parry S, Goldblatt J, Baron JA, Burnett T, Le Marchand L, Newcomb PA, Haile RW, Hopper JL, Cotterchio M, Gallinger S, Lindor NM, Tucker KM, Winship IM, Jenkins MA. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014;146:1208-11.e1-5. [<a href="/pmc/articles/PMC3992182/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3992182</span></a>] [<a href="/pubmed/24444654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24444654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.win.2017.404">Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN, Casey G, Gallinger S, Le Marchand L, Haile RW, Potter JD, Zheng Y, Lindor NM, Newcomb PA, Hopper JL, MacInnis RJ. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2017;<span class="ref-vol">26</span>:404–12.</span> [<a href="/pmc/articles/PMC5336409/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5336409</span></a>] [<a href="/pubmed/27799157" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27799157</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.win.2016.1557">Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, Southey MC, Young JP, Cleary SP, Kim H. Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. <span><span class="ref-journal">Int J Cancer. </span>2016;<span class="ref-vol">139</span>:1557–63.</span> [<a href="/pmc/articles/PMC5094810/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5094810</span></a>] [<a href="/pubmed/27194394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27194394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="maps.REF.yanarufujisawa.2008.545">Yanaru-Fujisawa R, Matsumoto T, Ushijima Y, Esaki M, Hirahashi M, Gushima M, Yao T, Nakabeppu Y, Iida M. Genomic and functional analyses of MUTYH in Japanese patients with adenomatous polyposis. <span><span class="ref-journal">Clin Genet. </span>2008;<span class="ref-vol">73</span>:545–53.</span> [<a href="/pubmed/18422726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18422726</span></a>]</div></li></ul></div></div><div id="maps.Chapter_Notes"><h2 id="_maps_Chapter_Notes_">Chapter Notes</h2><div id="maps.Acknowledgments"><h3>Acknowledgments</h3><p>The authors of this manuscript would like to thank Beth Dudley, MS, MPH, CGC for her assistance in editing and providing feedback about this <i>GeneReview</i>.</p></div><div id="maps.Author_History"><h3>Author History</h3><p>Randall Brand, MD (2012-present)<br />Elena Infante, MS, CGC (2012-present)<br />Henry Lynch, MD; Creighton University (2012-2019)<br />Maartje Nielsen, MD (2012-present)</p></div><div id="maps.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>10 October 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 September 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 October 2012 (me) Review posted live</div></li><li class="half_rhythm"><div>21 June 2011 (ei) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK107219</span><span class="label">PMID: <a href="/pubmed/23035301" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">23035301</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mpv17-mtdep/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/myh9/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK107219&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK107219/?report=reader">PubReader</a></li><li><a href="/books/NBK107219/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK107219" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK107219" style="display:none" title="Cite this Page"><div class="bk_tt">Nielsen M, Infante E, Brand R. MUTYH Polyposis. 2012 Oct 4 [Updated 2019 Oct 10]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK107219/pdf/Bookshelf_NBK107219.pdf">PDF version of this page</a> (558K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#maps.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#maps.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#maps.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#maps.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#maps.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#maps.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#maps.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#maps.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#maps.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#maps.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#maps.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4595[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MUTYH</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK107219+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2980000" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2980000" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2980000" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2980000" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301519" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">APC</i>-Associated Polyposis Conditions</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">APC</i>-Associated Polyposis Conditions<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jasperson KW, Patel SG, Ahnen DJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19822006" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial adenomatous polyposis.</a><span class="source">[Orphanet J Rare Dis. 2009]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial adenomatous polyposis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Half E, Bercovich D, Rozen P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2009 Oct 12; 4:22. Epub 2009 Oct 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301642" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Juvenile Polyposis Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Juvenile Polyposis Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Larsen Haidle J, Howe JR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30640315" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Endoscopic Phenotype of Monoallelic Carriers of MUTYH Gene Mutations in the Family of Polyposis Patients: A Prospective Study.</a><span class="source">[Dis Colon Rectum. 2019]</span><div class="brieflinkpop offscreen_noflow">Endoscopic Phenotype of Monoallelic Carriers of MUTYH Gene Mutations in the Family of Polyposis Patients: A Prospective Study.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El Hachem N, Abadie C, Longy M, Colas C, Fert-Ferrer S, Leroux D, Grandval P, Prieur F, Collonge-Rame M, Faivre L, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Dis Colon Rectum. 2019 Apr; 62(4):470-475. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22158503" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MUTYH-associated colon disease: adenomatous polyposis is only one of the possible phenotypes. A family report and literature review.</a><span class="source">[Tumori. 2011]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MUTYH-associated colon disease: adenomatous polyposis is only one of the possible phenotypes. A family report and literature review.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Zorcolo L, Fantola G, Balestrino L, Restivo A, Vivanet C, Spina F, Cabras F, Ambu R, Casula G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Tumori. 2011 Sep-Oct; 97(5):676-80. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=23035301" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=23035301" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041422dde0891169cb8085">MUTYH Polyposis - GeneReviews®</a><div class="ralinkpop offscreen_noflow">MUTYH Polyposis - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:00:03-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CEE00E04048610000000006890249&amp;ncbi_session=CE8CEE00E0414221_1673SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK107219%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK107219&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK107219/&amp;ncbi_pagename=MUTYH Polyposis - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CEE00E0414221_1673SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>